Biogen Inc. (BIIB) NASDAQ

$215.49 (0.85) (-0.39%)

Market Cap: $31.45B

As of 03/28/24 03:59 PM EDT. Market closed.

(BIIB)

Biogen Inc. (BIIB)
NASDAQ

$215.49
(0.85) (-0.39%)

Market Cap: $31.45B

As of 03/28/24 03:59 PM EDT. Market closed.

Add to Portfolio

through cutting-edge science and medicine, biogen discovers, develops and delivers innovative therapies worldwide for people living with serious neurological and neurodegenerative diseases. founded in 1978, biogen is a pioneer in biotechnology and today the company has the leading portfolio of medicines to treat multiple sclerosis, has introduced the first and only approved treatment for spinal ... read more

through cutting-edge science and medicine, biogen discovers, develops and delivers innovative therapies worldwide for people living with serious neurological and neurodegenerative diseases. founded in 1978, biogen is a pioneer in biotechnology and today the company has the leading portfolio of medicines to treat multiple sclerosis, has introduced the first and only approved treatment for spinal muscular atrophy, and is at the forefront of neurology research for conditions including alzheimer’s disease, parkinson’s disease and amyotrophic lateral sclerosis. biogen also manufactures and commercializes biosimilars of advanced biologics. with approximately 7000 people worldwide, we are truly a global organization, headquartered in cambridge, massachusetts, which is also home to our research operations. our international headquarters are based in zug, switzerland and we have world-class manufacturing facilities in north carolina and denmark. we offer therapies globally through direct affili read less

COMPANY PROFILE
Sector
Manufacturing
Industry
Biological Product (except Diagnostic) Manufacturing
CEO
George Scangos
Full Time Employees
13,414
CEO Compensation (Base)
$1.28M
CEO Compensation (Total)
$16.17M
URL
Address
225 Binney St, Massachusetts, Cambridge, 02142-1031.
Sector
Manufacturing
Industry
Biological Product (except Diagnostic) Manufacturing
CEO
George Scangos
Full Time Employees
13,414
CEO Compensation (Base)
$1.28M
CEO Compensation (Total)
$16.17M
Address
225 Binney St, Massachusetts, Cambridge, 02142-1031.
PRICE CHART FOR BIOGEN INC
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$217.26
Previous Close
$216.34
Days Range
$212.95 - $216.34
52 week range
$211.02 - $319.76
Volume
1,760,418
Avg. Volume (30 days)
1,339,291
Market Cap
$31.45B
Dividend Yield
-
P/E
27.08
Shares Outstanding
145,360,798
Open
$217.26
Previous Close
$216.34
Days Range
$212.95 - $216.34
52 week range
$211.02 - $319.76
Volume
1,760,418
Avg. Volume (30 days)
1,339,291
Market Cap
$31.45B
Dividend Yield
-
P/E
27.08
Shares Outstanding
145,360,798
FINANCIAL STATEMENTS FOR BIOGEN INC
LOADING...

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR BIOGEN INC
OwnerRelationshipDateTransactionCost# SharesValue($)Total SharesForm 4
Singhal PriyaHead of DevelopmentFeb 22, 2024 Sale$221.2326257,9624,886Feb 26, 2024, 07:54 PM
ALEXANDER SUSAN HEVP Chief Legal OfficerFeb 16, 2024 Option Exercise$219.082,437533,89851,683Feb 21, 2024, 09:39 PM
Gregory GingerEVP, Human ResourcesFeb 16, 2024 Option Exercise$219.082,264495,99713,584Feb 21, 2024, 09:36 PM
Izzar RachidHead of Global Product Strat.Feb 16, 2024 Option Exercise$219.08952208,5649,701Feb 21, 2024, 09:33 PM
Kramer RobinChief Accounting OfficerFeb 16, 2024 Option Exercise$219.0839686,7566,227Feb 21, 2024, 09:31 PM
MCDONNELL MICHAEL REVP, Chief Financial OfficerFeb 16, 2024 Option Exercise$219.083,438753,19719,406Feb 21, 2024, 09:29 PM
Murphy NicoleHead of Pharm Ops and TechFeb 16, 2024 Option Exercise$219.08610133,6399,418Feb 21, 2024, 09:28 PM
Singhal PriyaHead of DevelopmentFeb 16, 2024 Option Exercise$219.08468102,5295,256Feb 21, 2024, 09:27 PM
Singhal PriyaHead of DevelopmentFeb 16, 2024 Sale$221.4910823,9215,148Feb 21, 2024, 09:27 PM
Rowinsky Eric KDirectorFeb 15, 2024 Buy$222.54455101,25620,629Feb 20, 2024, 09:13 PM
Gregory GingerEVP, Human ResourcesFeb 09, 2024 Option Exercise$240.98634152,78111,144Feb 13, 2024, 06:14 PM
Singhal PriyaHead of DevelopmentFeb 09, 2024 Option Exercise$240.9837490,1274,935Feb 13, 2024, 06:06 PM
Singhal PriyaHead of DevelopmentFeb 12, 2024 Sale$239.45419100,3304,516Feb 13, 2024, 06:06 PM
Murphy NicoleHead of Pharm Ops and TechFeb 09, 2024 Option Exercise$240.98761183,3868,768Feb 13, 2024, 06:04 PM
MCDONNELL MICHAEL REVP, Chief Financial OfficerFeb 09, 2024 Option Exercise$240.981,431344,84216,124Feb 13, 2024, 06:03 PM
Kramer RobinChief Accounting OfficerFeb 09, 2024 Option Exercise$240.9824559,0405,278Feb 13, 2024, 06:01 PM
Izzar RachidHead of Global Product Strat.Feb 09, 2024 Option Exercise$240.98445107,2368,636Feb 13, 2024, 06:00 PM
ALEXANDER SUSAN HEVP Chief Legal OfficerFeb 09, 2024 Option Exercise$240.98938226,03949,083Feb 13, 2024, 05:56 PM
ALEXANDER SUSAN HEVP Chief Legal OfficerFeb 08, 2024 Option Exercise$240.30655157,39747,446Feb 09, 2024, 08:16 PM
Gregory GingerEVP, Human ResourcesFeb 08, 2024 Option Exercise$240.30498119,6699,620Feb 09, 2024, 08:14 PM
Izzar RachidHead of Global Product Strat.Feb 08, 2024 Option Exercise$240.30621149,2267,566Feb 09, 2024, 08:11 PM
Kramer RobinChief Accounting OfficerFeb 08, 2024 Option Exercise$240.3025360,7964,690Feb 09, 2024, 08:06 PM
MCDONNELL MICHAEL REVP, Chief Financial OfficerFeb 08, 2024 Option Exercise$240.30765183,83014,298Feb 09, 2024, 08:03 PM
Murphy NicoleHead of Pharm Ops and TechFeb 08, 2024 Option Exercise$240.30638153,3117,257Feb 09, 2024, 08:01 PM
Singhal PriyaHead of DevelopmentFeb 01, 2024 Option Exercise$247.83561139,0334,731Feb 05, 2024, 06:38 PM
Singhal PriyaHead of DevelopmentFeb 02, 2024 Sale$245.93634155,9204,097Feb 05, 2024, 06:38 PM
Singhal PriyaHead of DevelopmentDec 08, 2023 Option Exercise$239.2920649,2943,574Dec 12, 2023, 05:06 PM
Singhal PriyaHead of DevelopmentDec 11, 2023 Sale$248.0011027,2803,464Dec 12, 2023, 05:06 PM
Kramer RobinChief Accounting OfficerDec 08, 2023 Option Exercise$239.2917040,6794,155Dec 12, 2023, 05:02 PM
MCDONNELL MICHAEL REVP, Chief Financial OfficerSep 01, 2023 Option Exercise$267.172,704722,42812,728Sep 06, 2023, 06:08 PM
Singhal PriyaHead of DevelopmentSep 01, 2023 Option Exercise$267.17807215,6063,785Sep 06, 2023, 06:06 PM
Singhal PriyaHead of DevelopmentSep 05, 2023 Sale$269.43431116,1243,354Sep 06, 2023, 06:06 PM
Izzar RachidHead of Global Product Strat.Jun 30, 2023 Option Exercise$284.8524469,5036,144Jul 05, 2023, 05:37 PM
Kramer RobinChief Accounting OfficerJun 30, 2023 Option Exercise$284.8512234,7523,974Jul 05, 2023, 05:35 PM
Singhal PriyaHead of DevelopmentJun 30, 2023 Option Exercise$284.8515343,5823,005Jul 05, 2023, 05:33 PM
Singhal PriyaHead of DevelopmentJul 03, 2023 Sale$282.878122,9122,924Jul 05, 2023, 05:33 PM
Gregory GingerEVP, Human ResourcesApr 28, 2023 Sale$300.002,681804,3008,483May 02, 2023, 08:05 PM
Singhal PriyaHead of DevelopmentApr 04, 2023 Sale$277.119125,2172,843Apr 06, 2023, 06:37 PM
Murphy NicoleHead of Pharm Ops and TechMar 31, 2023 Option Exercise$278.0311632,2515,702Apr 04, 2023, 05:21 PM
Singhal PriyaHead of DevelopmentMar 28, 2023 Sale$270.06568153,3942,842Mar 30, 2023, 06:31 PM
Singhal PriyaHead of DevelopmentMar 02, 2023 Option Exercise$268.75687184,6313,410Mar 06, 2023, 06:13 PM
Singhal PriyaHead of DevelopmentFeb 17, 2023 Option Exercise$278.3815142,0353,800Feb 22, 2023, 05:07 PM
Murphy NicoleHead of Pharm Ops and TechFeb 17, 2023 Option Exercise$278.3823364,8635,099Feb 22, 2023, 05:06 PM
MCDONNELL MICHAEL REVP, Chief Financial OfficerFeb 17, 2023 Option Exercise$278.381,310364,6787,586Feb 22, 2023, 05:03 PM
Kramer RobinChief Accounting OfficerFeb 17, 2023 Option Exercise$278.3823866,2543,332Feb 22, 2023, 05:01 PM
Izzar RachidHead of Global Product Strat.Feb 17, 2023 Option Exercise$278.38371103,2795,117Feb 22, 2023, 04:57 PM
Gregory GingerEVP, Human ResourcesFeb 17, 2023 Option Exercise$278.38867241,3559,280Feb 22, 2023, 04:54 PM
ALEXANDER SUSAN HEVP Chief Legal Off & Corp SecFeb 17, 2023 Option Exercise$278.38929258,61545,911Feb 22, 2023, 04:49 PM
ALEXANDER SUSAN HEVP Chief Legal Off & Corp SecFeb 10, 2023 Option Exercise$286.304,2021,203,03347,657Feb 14, 2023, 09:46 PM
Gregory GingerEVP, Human ResourcesFeb 10, 2023 Option Exercise$286.303,306946,50812,257Feb 14, 2023, 09:44 PM
Izzar RachidHead of Global Product Strat.Feb 10, 2023 Option Exercise$286.301,324379,0616,130Feb 14, 2023, 09:41 PM
Kramer RobinChief Accounting OfficerFeb 10, 2023 Option Exercise$286.30590168,9173,831Feb 14, 2023, 09:37 PM
MCDONNELL MICHAEL REVP, Chief Financial OfficerFeb 10, 2023 Option Exercise$286.301,105316,3618,896Feb 14, 2023, 09:25 PM
Murphy NicoleHead of Pharm Ops and TechFeb 10, 2023 Option Exercise$286.301,387397,0985,694Feb 14, 2023, 09:23 PM
Singhal PriyaHead of DevelopmentFeb 10, 2023 Option Exercise$286.30372106,5043,491Feb 14, 2023, 09:21 PM
Gregory GingerEVP, Human ResourcesNov 14, 2022 Sale$300.115,6101,683,6175,711Dec 12, 2022, 08:00 PM
Kramer RobinChief Accounting OfficerDec 08, 2022 Option Exercise$289.1015645,1002,212Dec 12, 2022, 06:04 PM
Izzar RachidHead of Alzheimer's DiseaseDec 02, 2022 Option Exercise$298.90759226,8653,061Dec 06, 2022, 06:37 PM
Murphy NicoleHead of Pharm Ops and TechDec 02, 2022 Option Exercise$298.903911,6572,768Dec 06, 2022, 06:33 PM
ALEXANDER SUSAN HEVP Chief Legal Off & Corp SecOct 27, 2022 Sale$280.705,5321,552,83239,396Oct 28, 2022, 07:19 PM
MCDONNELL MICHAEL REVP, Chief Financial OfficerSep 01, 2022 Option Exercise$199.792,428485,0906,745Sep 06, 2022, 07:31 PM
Murphy NicoleHead of Pharm Ops and TechAug 01, 2022 Option Exercise$209.2631966,7542,676Aug 03, 2022, 05:40 PM
Kramer RobinChief Accounting OfficerJul 01, 2022 Option Exercise$210.637415,5872,018Jul 06, 2022, 07:33 PM
Izzar RachidHead of Alzheimer's DiseaseJul 01, 2022 Option Exercise$210.6314831,1732,110Jul 06, 2022, 07:28 PM
Murphy NicoleHead of Pharm Ops and TechApr 01, 2022 Option Exercise$210.658417,6951,813Apr 05, 2022, 05:44 PM
Vounatsos MichelChief Executive OfficerFeb 18, 2022 Option Exercise$209.792,746576,08367,261Feb 23, 2022, 04:21 PM
Murphy NicoleHead of Pharm Ops and TechFeb 18, 2022 Option Exercise$209.7911023,0771,658Feb 23, 2022, 04:20 PM
MCDONNELL MICHAEL REVP, Chief Financial OfficerFeb 18, 2022 Option Exercise$209.79977204,9654,427Feb 23, 2022, 04:19 PM
Gregory GingerEVP, Human ResourcesFeb 18, 2022 Option Exercise$209.79616129,23111,219Feb 23, 2022, 04:15 PM
ALEXANDER SUSAN HEVP Chief Legal Off & Corp SecFeb 18, 2022 Option Exercise$209.79659138,25244,928Feb 23, 2022, 04:14 PM
ALEXANDER SUSAN HEVP Chief Legal Off & Corp SecFeb 12, 2022 Option Exercise$214.592,056441,19745,146Feb 15, 2022, 04:17 PM
Gregory GingerEVP, Human ResourcesFeb 12, 2022 Option Exercise$214.591,252268,66711,032Feb 15, 2022, 04:16 PM
Guindo ChirfiHead of Glob Prod Strat & ComFeb 12, 2022 Option Exercise$214.592,342502,5707,451Feb 15, 2022, 04:15 PM
Kramer RobinChief Accounting OfficerDec 03, 2021 Option Exercise$223.9210022,3921,132Dec 07, 2021, 04:09 PM
Kramer RobinChief Accounting OfficerDec 03, 2021 Option Exercise$223.9233975,9091,210Dec 07, 2021, 04:09 PM
Izzar RachidHead of Alzheimer's DiseaseDec 02, 2021 Option Exercise$228.5216537,7061,106Dec 06, 2021, 04:14 PM
Izzar RachidHead of Alzheimer's DiseaseDec 02, 2021 Option Exercise$228.5237285,0091,271Dec 06, 2021, 04:14 PM
MCDONNELL MICHAEL REVP, Chief Financial OfficerSep 01, 2021 Option Exercise$338.242,582873,3363,423Sep 03, 2021, 04:08 PM
MCDONNELL MICHAEL REVP, Chief Financial OfficerSep 01, 2021 Option Exercise$338.246,0052,031,1314,864Sep 03, 2021, 04:08 PM
Kramer RobinChief Accounting OfficerJul 01, 2021 Option Exercise$348.927425,820871Jul 02, 2021, 04:34 PM
Kramer RobinChief Accounting OfficerJul 01, 2021 Option Exercise$348.9225187,579945Jul 02, 2021, 04:34 PM
Sandrock AlfredHead of Research & DevelopmentJun 07, 2021 Sale$440.007,6723,375,68010,169Jun 09, 2021, 07:05 PM
Guindo ChirfiHead of Glob Prod Strat & ComJun 07, 2021 Sale$440.003,0871,358,2802,919Jun 09, 2021, 07:04 PM
Posner Brian SDirectorJun 04, 2021 Sale$274.1736098,7017,400Jun 07, 2021, 07:02 PM
Vounatsos MichelChief Executive OfficerFeb 12, 2021 Option Exercise$278.0314,4734,023,92857,669Feb 17, 2021, 05:03 PM
Sandrock AlfredEVP, Research & DevelopmentFeb 12, 2021 Option Exercise$278.033,510975,88519,138Feb 17, 2021, 05:01 PM
Kramer RobinSVP, Chief Accounting OfficerFeb 12, 2021 Option Exercise$278.0311531,973664Feb 17, 2021, 04:59 PM
Gregory GingerEVP, Human ResourcesFeb 12, 2021 Option Exercise$278.032,182606,6618,892Feb 17, 2021, 04:56 PM
Galdes AlphonseEVP Pharmaceutical Oper & TechFeb 12, 2021 Option Exercise$278.03715198,7914,681Feb 17, 2021, 04:54 PM
ALEXANDER SUSAN HEVP Chief Legal Off & Corp SecFeb 12, 2021 Option Exercise$278.033,8961,083,20542,805Feb 17, 2021, 04:52 PM
Guindo ChirfiEVP Glob. Prod Strat and CommFeb 12, 2021 Option Exercise$278.03940261,3486,483Feb 17, 2021, 12:00 AM
Mantas Jesus BDirectorFeb 09, 2021 Buy$267.00898239,7662,943Feb 10, 2021, 04:31 PM
Kramer RobinVP, Chief Accounting OfficerDec 03, 2020 Option Exercise$244.09225,370373Dec 07, 2020, 09:08 PM
Guindo ChirfiEVP Glob. Prod Strat and CommDec 01, 2020 Option Exercise$243.16562136,6563,790Dec 03, 2020, 05:41 PM
Vounatsos MichelChief Executive OfficerNov 30, 2020 Buy$241.303,100748,04534,810Dec 01, 2020, 04:57 PM
Sandrock AlfredEVP, Research & DevelopmentNov 04, 2020 Sale$350.001,500525,00013,066Nov 06, 2020, 09:39 PM
Gregory GingerEVP, Human ResourcesJul 31, 2020 Option Exercise$274.6922361,2564,691Aug 04, 2020, 04:12 PM
SHERWIN STEPHEN ADirectorMar 11, 2020 Option Exercise$58.4612,278717,77216,517Mar 12, 2020, 06:56 PM
SHERWIN STEPHEN ADirectorMar 11, 2020 Sale$295.222,434718,57415,438Mar 12, 2020, 06:56 PM
Vounatsos MichelChief Executive OfficerFeb 15, 2020 Option Exercise$333.002,150715,95031,625Feb 19, 2020, 06:20 PM
Sandrock AlfredEVP, Research & DevelopmentFeb 15, 2020 Option Exercise$333.00538179,15414,481Feb 19, 2020, 06:17 PM
Galdes AlphonseEVP Pharmaceutical Oper & TechFeb 15, 2020 Option Exercise$333.0013043,2902,542Feb 19, 2020, 06:13 PM
ALEXANDER SUSAN HEVP Chief Legal Off & Corp SecFeb 15, 2020 Option Exercise$333.00689229,43736,572Feb 19, 2020, 06:09 PM
Kramer RobinVP, Chief Accounting OfficerFeb 12, 2020 Option Exercise$331.764615,261236Feb 14, 2020, 06:37 PM
Karp DanielEVP, Corporate DevelopmentFeb 12, 2020 Option Exercise$331.7629497,537930Feb 14, 2020, 06:36 PM
Guindo ChirfiEVP Glob. Prod Strat and CommFeb 12, 2020 Option Exercise$331.76504167,2073,871Feb 14, 2020, 06:34 PM
Gregory GingerEVP, Human ResourcesFeb 12, 2020 Option Exercise$331.761,159384,5104,603Feb 14, 2020, 06:32 PM
Galdes AlphonseEVP Pharmaceutical Oper & TechFeb 12, 2020 Option Exercise$331.76351116,4482,231Feb 14, 2020, 06:30 PM
CAPELLO JEFFREY DEVP & Chief Financial OfficerFeb 12, 2020 Option Exercise$331.76614203,7013,118Feb 14, 2020, 06:27 PM
ALEXANDER SUSAN HEVP Chief Legal Off & Corp SecFeb 12, 2020 Option Exercise$331.762,235741,48435,708Feb 14, 2020, 06:25 PM
Vounatsos MichelChief Executive OfficerFeb 12, 2020 Option Exercise$331.764,8951,623,96528,928Feb 14, 2020, 06:19 PM
Sandrock AlfredEVP, Research & DevelopmentFeb 12, 2020 Option Exercise$331.761,901630,67613,806Feb 14, 2020, 06:16 PM
CAPELLO JEFFREY DEVP & Chief Financial OfficerJan 02, 2020 Option Exercise$294.20406119,4451,813Jan 06, 2020, 12:00 AM
Kramer RobinVP, Chief Accounting OfficerDec 03, 2019 Option Exercise$290.70257,268150Dec 05, 2019, 04:24 PM
Guindo ChirfiEVP Glob. Prod Strat and CommDec 01, 2019 Option Exercise$299.81391117,2262,695Dec 03, 2019, 05:59 PM
Posner Brian SDirectorDec 02, 2019 Sale$292.351,055308,4296,995Dec 03, 2019, 05:58 PM
Gregory GingerEVP, Human ResourcesAug 01, 2019 Option Exercise$243.0620850,5562,215Aug 05, 2019, 04:20 PM
Karp DanielEVP, Corporate DevelopmentJul 02, 2019 Option Exercise$236.375813,709264Jul 05, 2019, 04:51 PM
Ehlers Michael DEVP, Research and DevelopmentJun 01, 2019 Option Exercise$219.29960210,5188,025Jun 04, 2019, 04:56 PM
Vounatsos MichelChief Executive OfficerMay 02, 2019 Option Exercise$230.52658151,68221,829May 06, 2019, 04:20 PM
DENNER ALEXANDER JDirectorMay 02, 2019 Buy$231.2438,0008,787,120643,000May 02, 2019, 05:06 PM
DENNER ALEXANDER JDirectorMay 01, 2019 Buy$229.4630,0006,883,800605,000May 02, 2019, 05:06 PM
DENNER ALEXANDER JDirectorApr 30, 2019 Buy$229.2550,34211,540,904575,000May 02, 2019, 05:06 PM
Vounatsos MichelChief Executive OfficerMay 01, 2019 Buy$231.484,3511,007,16921,007May 02, 2019, 04:30 PM
PANGIA ROBERT WDirectorMar 18, 2019 Option Exercise$52.226,114319,27324,701Mar 19, 2019, 04:08 PM
PANGIA ROBERT WDirectorMar 18, 2019 Sale$328.556,1142,008,75518,587Mar 19, 2019, 04:08 PM
McKenzie PaulEVP Pharmaceutical Oper & TechMar 01, 2019 Option Exercise$334.10658219,8387,235Mar 05, 2019, 12:00 AM
ALEXANDER SUSAN HEVP Chief Legal Officer & Sec.Feb 22, 2019 Option Exercise$325.334,1091,336,78132,715Feb 26, 2019, 05:09 PM
ALEXANDER SUSAN HEVP Chief Legal Officer & Sec.Feb 22, 2019 Option Exercise$48.526,395310,28536,085Feb 26, 2019, 05:09 PM
Sandrock AlfredEVP, Chief Medical OfficerFeb 22, 2019 Option Exercise$325.33739240,41910,409Feb 26, 2019, 05:07 PM
Vounatsos MichelChief Executive OfficerFeb 15, 2019 Option Exercise$332.872,340778,91616,574Feb 20, 2019, 06:10 PM
Sandrock AlfredEVP, Chief Medical OfficerFeb 15, 2019 Option Exercise$332.87586195,0629,485Feb 20, 2019, 06:08 PM
McKenzie PaulEVP Pharmaceutical Oper & TechFeb 15, 2019 Option Exercise$332.87643214,0357,325Feb 20, 2019, 06:07 PM
Ehlers Michael DEVP, Research and DevelopmentFeb 15, 2019 Option Exercise$332.87749249,3207,777Feb 20, 2019, 05:54 PM
ALEXANDER SUSAN HEVP Chief Legal Officer & Sec.Feb 15, 2019 Option Exercise$332.87749249,32028,027Feb 20, 2019, 05:53 PM
Vounatsos MichelChief Executive OfficerFeb 12, 2019 Option Exercise$319.432,622837,54513,645Feb 14, 2019, 06:33 PM
Sandrock AlfredEVP, Chief Medical OfficerFeb 12, 2019 Option Exercise$319.432,518804,3258,753Feb 14, 2019, 06:29 PM
McKenzie PaulEVP Pharmaceutical Oper & TechFeb 12, 2019 Option Exercise$319.43919293,5566,520Feb 14, 2019, 06:17 PM
Gregory GingerEVP, Human ResourcesFeb 12, 2019 Option Exercise$319.43551176,0062,244Feb 14, 2019, 06:10 PM
Ehlers Michael DEVP, Research and DevelopmentFeb 12, 2019 Option Exercise$319.431,267404,7186,841Feb 14, 2019, 06:07 PM
ALEXANDER SUSAN HEVP Chief Legal Officer & Sec.Feb 12, 2019 Option Exercise$319.431,021326,13827,091Feb 14, 2019, 06:04 PM
DENNER ALEXANDER JDirectorJan 30, 2019 Buy$324.8630,0009,745,860491,858Feb 01, 2019, 04:19 PM
DENNER ALEXANDER JDirectorFeb 01, 2019 Buy$328.457,0002,299,164524,658Feb 01, 2019, 04:19 PM
DENNER ALEXANDER JDirectorJan 31, 2019 Buy$330.5225,8008,527,391517,658Feb 01, 2019, 04:19 PM
CAPELLO JEFFREY DEVP & Chief Financial OfficerJan 02, 2019 Option Exercise$304.69414126,142917Jan 04, 2019, 04:17 PM
Guindo ChirfiEVP Glob. Mkt Acc & Cust InnovDec 01, 2018 Option Exercise$333.72409136,4912,543Dec 04, 2018, 08:21 PM
Ehlers Michael DEVP, Research and DevelopmentSep 26, 2018 Sale$350.001,000350,0004,281Sep 27, 2018, 04:16 PM
Gregory GingerEVP, Human ResourcesAug 01, 2018 Option Exercise$344.0616356,0821,044Aug 03, 2018, 04:14 PM
Ehlers Michael DEVP, Research and DevelopmentJun 01, 2018 Option Exercise$297.091,076319,6695,281Jun 05, 2018, 04:31 PM
Vounatsos MichelChief Executive OfficerMay 02, 2018 Option Exercise$274.13750205,5989,368May 04, 2018, 06:09 PM
DENNER ALEXANDER JDirectorApr 25, 2018 Buy$269.9148,00012,955,680461,858Apr 27, 2018, 07:48 AM
McKenzie PaulEVP Pharmaceutical Oper & TechMar 01, 2018 Option Exercise$282.35642181,2694,302Mar 05, 2018, 04:41 PM
Sandrock AlfredEVP, Chief Medical OfficerFeb 27, 2018 Sale$290.8325975,3256,553Feb 28, 2018, 05:39 PM
Sandrock AlfredEVP, Chief Medical OfficerFeb 23, 2018 Option Exercise$292.7820860,8986,812Feb 27, 2018, 06:25 PM
Sandrock AlfredEVP, Chief Medical OfficerFeb 23, 2018 Sale$293.44908266,4446,553Feb 27, 2018, 06:25 PM
COVINO GREGORY FVP, Chief Accounting OfficerFeb 23, 2018 Option Exercise$292.78288,1984,744Feb 27, 2018, 06:24 PM
ALEXANDER SUSAN HEVP Chief Legal Corp Svc & SecFeb 23, 2018 Option Exercise$292.78381111,54924,844Feb 27, 2018, 06:22 PM
Sandrock AlfredEVP, Chief Medical OfficerFeb 22, 2018 Option Exercise$284.81727207,0577,461Feb 26, 2018, 04:12 PM
COVINO GREGORY FVP, Chief Accounting OfficerFeb 22, 2018 Option Exercise$284.815816,5194,680Feb 26, 2018, 12:00 AM
ALEXANDER SUSAN HEVP Chief Legal Corp Svc & SecFeb 22, 2018 Option Exercise$284.81727207,05724,368Feb 26, 2018, 12:00 AM
Sandrock AlfredEVP, Chief Medical OfficerFeb 20, 2018 Sale$292.00743216,9566,553Feb 21, 2018, 04:10 PM
Sandrock AlfredEVP, Chief Medical OfficerFeb 15, 2018 Sale$298.851,294386,7127,296Feb 20, 2018, 08:09 PM
Vounatsos MichelChief Executive OfficerFeb 15, 2018 Option Exercise$299.381,877561,9368,356Feb 20, 2018, 04:27 PM
Sandrock AlfredEVP, Chief Medical OfficerFeb 15, 2018 Option Exercise$299.38596178,4308,590Feb 20, 2018, 04:25 PM
Ehlers Michael DEVP, Research and DevelopmentFeb 15, 2018 Option Exercise$299.38509152,3844,898Feb 20, 2018, 04:20 PM
ALEXANDER SUSAN HEVP Chief Legal Corp Svc & SecFeb 15, 2018 Option Exercise$299.38510152,68423,460Feb 20, 2018, 04:17 PM
COVINO GREGORY FVP, Chief Accounting OfficerFeb 15, 2018 Option Exercise$299.385616,7654,544Feb 20, 2018, 12:00 AM
McKenzie PaulEVP Pharmaceutical Oper & TechFeb 15, 2018 Option Exercise$299.38442132,3264,412Feb 20, 2018, 12:00 AM
Sandrock AlfredEVP, Chief Medical OfficerFeb 12, 2018 Option Exercise$316.631,316416,6857,847Feb 14, 2018, 06:37 PM
PANGIA ROBERT WDirectorJan 09, 2018 Option Exercise$57.835,832337,26523,539Jan 10, 2018, 05:28 PM
PANGIA ROBERT WDirectorJan 09, 2018 Sale$329.655,8321,922,51917,707Jan 10, 2018, 05:28 PM
Vounatsos MichelChief Executive OfficerDec 29, 2017 Buy$320.55780250,0294,879Jan 02, 2018, 04:21 PM
COVINO GREGORY FVP, Chief Accounting OfficerDec 01, 2017 Option Exercise$319.3515750,1384,542Dec 05, 2017, 04:36 PM
DENNER ALEXANDER JDirectorNov 29, 2017 Buy$319.8410,0003,198,400413,858Nov 30, 2017, 07:30 AM
DENNER ALEXANDER JDirectorNov 28, 2017 Buy$316.1220,0006,322,400403,858Nov 30, 2017, 07:30 AM
DENNER ALEXANDER JDirectorAug 31, 2017 Option Exercise$316.56933295,350383,858Aug 31, 2017, 09:45 PM
ALEXANDER SUSAN HEVP Chief Legal Corp Svc & SecJul 25, 2017 Sale$290.014,9741,442,51022,258Jul 26, 2017, 04:22 PM
ALEXANDER SUSAN HEVP Chief Legal Corp Svc & SecJul 19, 2017 Sale$285.007,7582,211,03027,232Jul 20, 2017, 05:00 PM
Posner Brian SDirectorJun 09, 2017 Sale$256.311,084277,8406,330Jun 12, 2017, 04:29 PM
Ehlers Michael DEVP, Research and DevelopmentJun 01, 2017 Option Exercise$252.38747188,5283,616Jun 05, 2017, 04:38 PM
Vounatsos MichelChief Executive OfficerMay 02, 2017 Option Exercise$271.34564153,0364,099May 04, 2017, 04:16 PM
Vounatsos MichelChief Executive OfficerMay 01, 2017 Buy$271.351,402380,4332,927May 02, 2017, 04:18 PM
DENNER ALEXANDER JDirectorApr 27, 2017 Buy$278.5073,85820,569,476383,858May 01, 2017, 05:47 PM
Clancy Paul JExecutive VP and CFOApr 25, 2017 Sale$290.009,8922,868,68010,813Apr 27, 2017, 04:23 PM
Clancy Paul JExecutive VP and CFOMar 13, 2017 Sale$291.559,8912,883,72120,705Mar 14, 2017, 07:32 PM
McKenzie PaulEVP Pharmaceutical Oper & TechMar 01, 2017 Option Exercise$293.2615746,042561Mar 03, 2017, 06:07 PM
Sandrock AlfredEVP CMO Neuro & NeurodegeneratMar 01, 2017 Sale$290.07973282,2389,041Mar 03, 2017, 06:02 PM
Clancy Paul JExecutive VP and CFOFeb 28, 2017 Option Exercise$279.353,054853,13530,596Mar 02, 2017, 05:24 PM
Sandrock AlfredEVP CMO Neuro & NeurodegeneratFeb 28, 2017 Option Exercise$278.172,981829,21710,014Mar 02, 2017, 05:22 PM
ALEXANDER SUSAN HEVP, Chief Legal OfficerFeb 28, 2017 Option Exercise$278.542,409670,99634,990Mar 02, 2017, 05:20 PM
COVINO GREGORY FVP, Chief Accounting OfficerFeb 28, 2017 Option Exercise$285.238925,3864,505Mar 02, 2017, 05:18 PM
Karaboutis AdrianaEVP, Tech, Bus. Sol & Corp AffFeb 28, 2017 Option Exercise$286.64738211,5428,752Mar 02, 2017, 05:16 PM
DiPietro KennethEVP Human ResourcesFeb 28, 2017 Option Exercise$278.662,456684,3997,177Mar 02, 2017, 05:12 PM
PANGIA ROBERT WDirectorJan 09, 2017 Option Exercise$52.225,450284,59922,078Jan 10, 2017, 04:15 PM
PANGIA ROBERT WDirectorJan 09, 2017 Sale$295.395,4501,609,87616,628Jan 10, 2017, 04:15 PM
Karaboutis AdrianaEVP, Tech, Bus. Sol & Corp AffDec 01, 2016 Option Exercise$295.7817150,5787,408Dec 05, 2016, 04:34 PM
Karaboutis AdrianaEVP, Tech, Bus. Sol & Corp AffDec 01, 2016 Sale$296.534814,2337,360Dec 05, 2016, 04:34 PM
COVINO GREGORY FVP, Chief Accounting OfficerDec 01, 2016 Option Exercise$295.785315,6763,884Dec 05, 2016, 04:32 PM
Karaboutis AdrianaEVP, Tech, Bus. Sol & Corp AffOct 04, 2016 Sale$311.9426281,7287,579Oct 05, 2016, 04:24 PM
Karaboutis AdrianaEVP, Tech, Bus. Sol & Corp AffOct 01, 2016 Option Exercise$313.031,888591,0018,221Oct 04, 2016, 05:02 PM
Karaboutis AdrianaEVP, Tech, Bus. Sol & Corp AffOct 03, 2016 Sale$313.00380118,9407,841Oct 04, 2016, 05:02 PM
DORSA CAROLINEDirectorSep 22, 2016 Option Exercise$53.6427,5701,478,85544,663Sep 26, 2016, 04:24 PM
DORSA CAROLINEDirectorSep 22, 2016 Sale$314.0027,5708,656,98017,093Sep 26, 2016, 04:24 PM
SCANGOS GEORGE AChief Executive OfficerJul 21, 2016 Sale$280.0015743,96054,779Jul 22, 2016, 05:03 PM
Koppel AdamEVP, Strategy and Bus. Dev.Jun 06, 2016 Sale$290.00555160,9502,402Jun 07, 2016, 04:09 PM
Koppel AdamEVP, Strategy and Bus. Dev.Jun 02, 2016 Option Exercise$289.73534154,7162,957Jun 06, 2016, 08:48 PM
SCANGOS GEORGE AChief Executive OfficerJun 03, 2016 Sale$290.00842244,18054,936Jun 06, 2016, 08:14 PM
SCANGOS GEORGE AChief Executive OfficerMay 31, 2016 Sale$290.003,368976,72056,265Jun 02, 2016, 04:39 PM
SCANGOS GEORGE AChief Executive OfficerJun 01, 2016 Sale$287.97487140,24155,778Jun 02, 2016, 04:39 PM
SCANGOS GEORGE AChief Executive OfficerMay 25, 2016 Sale$280.0015743,96059,633May 27, 2016, 08:59 AM
SCANGOS GEORGE AChief Executive OfficerMay 02, 2016 Sale$274.74487133,79859,790May 04, 2016, 05:03 PM
COVINO GREGORY FVP, Chief Accounting OfficerMay 01, 2016 Option Exercise$274.9911331,0743,007May 02, 2016, 04:36 PM
Koppel AdamEVP, Strategy and Bus. Dev.Apr 06, 2016 Sale$275.0010228,0501,848Apr 07, 2016, 05:03 PM
SCANGOS GEORGE AChief Executive OfficerApr 06, 2016 Sale$280.0015743,96060,277Apr 07, 2016, 05:01 PM
Artavanis-Tsakonas SpyridonEVP, Chief Scientific OfficerApr 02, 2016 Option Exercise$260.54459119,5883,150Apr 05, 2016, 05:06 PM
SCANGOS GEORGE AChief Executive OfficerApr 01, 2016 Sale$258.83487126,05060,434Apr 05, 2016, 05:02 PM
SCANGOS GEORGE AChief Executive OfficerMar 01, 2016 Sale$261.37487127,28760,921Mar 03, 2016, 04:36 PM
Sandrock AlfredEVP CMO Neuro & NeurodegeneratFeb 25, 2016 Sale$261.9018347,9287,990Feb 26, 2016, 04:08 PM
Karaboutis AdrianaEVP, Tech, Bus. Sol & Corp AffFeb 25, 2016 Sale$261.908422,0008,127Feb 26, 2016, 04:06 PM
Clancy Paul JExecutive VP and CFOFeb 23, 2016 Option Exercise$258.9927370,70426,870Feb 25, 2016, 05:13 PM
COVINO GREGORY FVP, Chief Accounting OfficerFeb 23, 2016 Option Exercise$258.99225,6982,687Feb 25, 2016, 05:09 PM
Artavanis-Tsakonas SpyridonSVP, Chief Scientific OfficerFeb 23, 2016 Option Exercise$258.994812,4322,549Feb 25, 2016, 05:07 PM
ALEXANDER SUSAN HEVP, Chief Legal OfficerFeb 23, 2016 Option Exercise$258.9930077,69731,840Feb 25, 2016, 05:05 PM
Cox JohnEVP Pharmaceutical Oper & TechFeb 23, 2016 Option Exercise$258.9938298,93430,516Feb 25, 2016, 05:04 PM
Koppel AdamEVP, Strategy and Bus. Dev.Feb 23, 2016 Option Exercise$258.999825,3811,865Feb 25, 2016, 05:02 PM
DiPietro KennethEVP Human ResourcesFeb 23, 2016 Option Exercise$258.9930077,6973,937Feb 25, 2016, 05:01 PM
Holtzman Steven HEVP Corporate DevelopmentFeb 23, 2016 Option Exercise$258.9927370,7048,326Feb 25, 2016, 04:59 PM
Karaboutis AdrianaEVP, Tech, Bus. Sol & Corp AffFeb 23, 2016 Option Exercise$258.9916241,9568,211Feb 25, 2016, 04:57 PM
Sandrock AlfredEVP CMO Neuro & NeurodegeneratFeb 23, 2016 Option Exercise$258.9916442,4748,173Feb 25, 2016, 04:52 PM
SCANGOS GEORGE AChief Executive OfficerFeb 23, 2016 Option Exercise$258.991,395361,29161,417Feb 25, 2016, 04:51 PM
SCANGOS GEORGE AChief Executive OfficerFeb 17, 2016 Sale$256.16487124,75059,848Feb 19, 2016, 04:20 PM
Sandrock AlfredEVP CMO Neuro & NeurodegeneratFeb 17, 2016 Sale$256.16722184,9487,990Feb 19, 2016, 04:18 PM
SCANGOS GEORGE AChief Executive OfficerFeb 12, 2016 Option Exercise$247.2211,8152,920,90460,335Feb 17, 2016, 06:03 PM
Cox JohnEVP Pharmaceutical Oper & TechFeb 12, 2016 Option Exercise$247.221,552383,68530,088Feb 17, 2016, 06:01 PM
DiPietro KennethEVP Human ResourcesFeb 12, 2016 Option Exercise$247.221,369338,4443,601Feb 17, 2016, 06:00 PM
COVINO GREGORY FVP, Chief Accounting OfficerFeb 12, 2016 Option Exercise$247.22266,4282,643Feb 17, 2016, 05:59 PM
Sandrock AlfredEVP CMO Neuro & NeurodegeneratFeb 12, 2016 Option Exercise$247.221,827451,6718,712Feb 17, 2016, 05:57 PM
Holtzman Steven HEVP Corporate DevelopmentFeb 12, 2016 Option Exercise$247.221,314324,8478,020Feb 17, 2016, 05:56 PM
ALEXANDER SUSAN HEVP, Chief Legal OfficerFeb 12, 2016 Option Exercise$247.221,328328,30831,504Feb 17, 2016, 05:55 PM
Artavanis-Tsakonas SpyridonSVP, Chief Scientific OfficerFeb 12, 2016 Option Exercise$247.2235287,0212,452Feb 17, 2016, 05:54 PM
Clancy Paul JExecutive VP and CFOFeb 12, 2016 Option Exercise$247.221,699420,02726,564Feb 17, 2016, 05:53 PM
SCANGOS GEORGE AChief Executive OfficerFeb 09, 2016 Option Exercise$249.995,3051,326,19747,059Feb 10, 2016, 04:19 PM
Sandrock AlfredEVP CMO Neuro & NeurodegeneratFeb 08, 2016 Option Exercise$250.77426106,8288,592Feb 10, 2016, 04:17 PM
Sandrock AlfredEVP CMO Neuro & NeurodegeneratFeb 09, 2016 Sale$246.54852210,0527,740Feb 10, 2016, 04:17 PM
ALEXANDER SUSAN HEVP, Chief Legal OfficerFeb 08, 2016 Option Exercise$250.77822206,13329,543Feb 09, 2016, 04:58 PM
Clancy Paul JExecutive VP and CFOFeb 08, 2016 Option Exercise$250.771,047262,55624,404Feb 09, 2016, 04:53 PM
Cox JohnEVP Pharmaceutical Oper & TechFeb 08, 2016 Option Exercise$250.771,324332,01928,342Feb 09, 2016, 04:51 PM
Holtzman Steven HEVP Corporate DevelopmentFeb 08, 2016 Option Exercise$250.77890223,1856,140Feb 09, 2016, 04:48 PM
DiPietro KennethEVP Human ResourcesFeb 01, 2016 Option Exercise$273.45812222,0411,654Feb 02, 2016, 04:05 PM
DiPietro KennethEVP Human ResourcesFeb 01, 2016 Option Exercise$273.452,466674,3282,466Feb 02, 2016, 04:05 PM
Sandrock AlfredEVP CMO Neuro & NeurodegeneratDec 03, 2015 Option Exercise$275.44393108,2488,181Dec 07, 2015, 04:20 PM
Sandrock AlfredEVP CMO Neuro & NeurodegeneratDec 04, 2015 Sale$277.00441122,1577,740Dec 07, 2015, 04:20 PM
Karaboutis AdrianaEVP, Tech. and Bus. SolutionsDec 01, 2015 Option Exercise$290.0417149,5977,923Dec 03, 2015, 04:19 PM
Karaboutis AdrianaEVP, Tech. and Bus. SolutionsDec 02, 2015 Sale$289.144813,8797,875Dec 03, 2015, 04:19 PM
DENNER ALEXANDER JDirectorOct 23, 2015 Buy$276.77100,00027,676,999310,000Oct 26, 2015, 07:03 PM
DENNER ALEXANDER JDirectorOct 22, 2015 Buy$277.80210,00058,337,997210,000Oct 26, 2015, 07:03 PM
Karaboutis AdrianaEVP, Tech. and Bus. SolutionsOct 05, 2015 Sale$291.4326978,3958,094Oct 06, 2015, 04:40 PM
Karaboutis AdrianaEVP, Tech. and Bus. SolutionsOct 01, 2015 Option Exercise$287.301,666478,6429,642Oct 05, 2015, 04:10 PM
Karaboutis AdrianaEVP, Tech. and Bus. SolutionsOct 02, 2015 Sale$283.38417118,1698,363Oct 05, 2015, 04:10 PM
PAPADOPOULOS STELIOSDirectorJul 27, 2015 Buy$304.985,0001,524,8955,000Jul 27, 2015, 05:03 PM
PAPADOPOULOS STELIOSDirectorJul 27, 2015 Buy$304.785,0001,523,8805,000Jul 27, 2015, 05:03 PM
Posner Brian SDirectorJun 22, 2015 Sale$415.00470195,0505,275Jun 23, 2015, 04:14 PM
WILLIAMS DOUGLAS EEVP Research & DevelopmentJun 19, 2015 Sale$410.003,8411,574,81011,817Jun 22, 2015, 04:15 PM
Posner Brian SDirectorJun 15, 2015 Sale$386.64400154,6565,745Jun 16, 2015, 06:54 PM
Koppel AdamSVP, Chief Strategy OfficerJun 02, 2015 Option Exercise$387.62852330,2521,662Jun 04, 2015, 05:49 PM
SCANGOS GEORGE AChief Executive OfficerJun 01, 2015 Sale$398.871,362543,26141,090Jun 02, 2015, 04:10 PM
COVINO GREGORY FVP, Chief Accounting OfficerMay 01, 2015 Option Exercise$386.2211343,6431,761May 05, 2015, 04:36 PM
COVINO GREGORY FVP, Chief Accounting OfficerMay 01, 2015 Option Exercise$386.22347134,0181,874May 05, 2015, 04:36 PM
SCANGOS GEORGE AChief Executive OfficerMay 01, 2015 Sale$377.521,362514,18242,452May 05, 2015, 04:34 PM
Artavanis-Tsakonas SpyridonSVP, Chief Scientific OfficerApr 02, 2015 Option Exercise$412.44460189,7221,674Apr 03, 2015, 04:24 PM
SCANGOS GEORGE AChief Executive OfficerApr 01, 2015 Sale$423.201,362576,39843,814Apr 02, 2015, 04:29 PM
Sandrock AlfredGrp SVP, Chief Medical OfficerMar 27, 2015 Sale$430.12430184,9528,574Mar 30, 2015, 04:13 PM
Cox JohnEVP Pharmaceutical Oper & TechMar 25, 2015 Option Exercise$65.855,066333,57137,577Mar 26, 2015, 04:31 PM
Cox JohnEVP Pharmaceutical Oper & TechMar 25, 2015 Sale$449.0612,0105,393,21125,567Mar 26, 2015, 04:31 PM
Rowinsky Eric KDirectorMar 20, 2015 Option Exercise$59.8211,667697,92022,977Mar 23, 2015, 04:33 PM
Rowinsky Eric KDirectorMar 20, 2015 Sale$475.0011,6675,541,82511,310Mar 23, 2015, 04:33 PM
Rowinsky Eric KDirectorMar 19, 2015 Option Exercise$59.822,333139,56013,643Mar 20, 2015, 05:03 PM
Rowinsky Eric KDirectorMar 19, 2015 Sale$436.142,3331,017,50811,310Mar 20, 2015, 05:03 PM
Rowinsky Eric KDirectorMar 17, 2015 Option Exercise$59.824,667279,18015,977Mar 18, 2015, 05:03 PM
Rowinsky Eric KDirectorMar 17, 2015 Sale$425.454,6671,985,58911,310Mar 18, 2015, 05:03 PM
DiPietro KennethEVP Human ResourcesMar 16, 2015 Sale$415.46803333,6140Mar 17, 2015, 08:10 PM
SCANGOS GEORGE AChief Executive OfficerMar 13, 2015 Sale$412.69537221,61345,176Mar 16, 2015, 08:39 PM
SHERWIN STEPHEN ADirectorMar 10, 2015 Option Exercise$59.826,000358,92010,150Mar 11, 2015, 04:17 PM
SHERWIN STEPHEN ADirectorMar 10, 2015 Sale$409.676,0002,458,0204,150Mar 11, 2015, 04:17 PM
Rowinsky Eric KDirectorMar 09, 2015 Option Exercise$59.824,666279,12015,976Mar 11, 2015, 04:15 PM
Rowinsky Eric KDirectorMar 09, 2015 Sale$417.234,6661,946,79511,310Mar 11, 2015, 04:15 PM
PANGIA ROBERT WDirectorMar 10, 2015 Option Exercise$47.713,625172,95417,998Mar 11, 2015, 04:13 PM
PANGIA ROBERT WDirectorMar 10, 2015 Sale$413.403,6251,498,57817,798Mar 11, 2015, 04:13 PM
Sandrock AlfredGrp SVP, Chief Medical OfficerMar 01, 2015 Option Exercise$409.592,8261,157,50112,178Mar 03, 2015, 04:44 PM
Sandrock AlfredGrp SVP, Chief Medical OfficerMar 02, 2015 Sale$409.493,1741,299,71512,078Mar 03, 2015, 04:44 PM
SCANGOS GEORGE AChief Executive OfficerMar 02, 2015 Sale$410.67825338,80345,713Mar 03, 2015, 04:39 PM
COVINO GREGORY FVP, Chief Accounting OfficerFeb 12, 2015 Option Exercise$392.1183,1371,302Feb 23, 2015, 04:24 PM
SCANGOS GEORGE AChief Executive OfficerFeb 19, 2015 Sale$401.04537215,35846,538Feb 20, 2015, 04:28 PM
SCANGOS GEORGE AChief Executive OfficerFeb 17, 2015 Sale$389.11825321,01647,075Feb 18, 2015, 04:45 PM
Holtzman Steven HEVP Corporate DevelopmentFeb 17, 2015 Sale$389.112,128828,0264,321Feb 18, 2015, 04:41 PM
DiPietro KennethEVP Human ResourcesFeb 17, 2015 Sale$389.111,188462,263803Feb 18, 2015, 04:37 PM
Sandrock AlfredGrp SVP, Chief Medical OfficerFeb 17, 2015 Sale$389.11418162,64815,004Feb 18, 2015, 04:36 PM
SCANGOS GEORGE AChief Executive OfficerFeb 12, 2015 Option Exercise$392.1112,1254,754,33447,900Feb 17, 2015, 09:32 PM
COVINO GREGORY FVP, Chief Accounting OfficerFeb 12, 2015 Option Exercise$392.11207,8421,446Feb 17, 2015, 09:16 PM
Holtzman Steven HEVP Corporate DevelopmentFeb 12, 2015 Option Exercise$392.111,712671,2926,449Feb 17, 2015, 08:54 PM
Artavanis-Tsakonas SpyridonSVP, Chief Scientific OfficerFeb 12, 2015 Option Exercise$392.11394154,4911,159Feb 17, 2015, 08:50 PM
Sandrock AlfredGrp SVP, Chief Medical OfficerFeb 12, 2015 Option Exercise$392.11757296,82715,422Feb 17, 2015, 08:47 PM
Clancy Paul JExecutive VP and CFOFeb 12, 2015 Option Exercise$392.112,026794,41522,257Feb 17, 2015, 08:44 PM
Cox JohnEVP Pharmaceutical Oper & TechFeb 12, 2015 Option Exercise$392.111,761690,50632,511Feb 17, 2015, 08:40 PM
WILLIAMS DOUGLAS EEVP Research & DevelopmentFeb 12, 2015 Option Exercise$392.112,450960,66915,658Feb 17, 2015, 08:37 PM
ALEXANDER SUSAN HEVP, Chief Legal OfficerFeb 12, 2015 Option Exercise$392.111,776696,38727,867Feb 17, 2015, 08:34 PM
DiPietro KennethEVP Human ResourcesFeb 12, 2015 Option Exercise$392.111,773695,2111,991Feb 17, 2015, 08:30 PM
Kingsley Stuart AEVP, Global Comm. OperationsFeb 12, 2015 Option Exercise$392.111,697665,4118,132Feb 17, 2015, 08:26 PM
Sandrock AlfredGrp SVP, Chief Medical OfficerFeb 10, 2015 Sale$398.111,143455,03915,417Feb 11, 2015, 04:26 PM
SCANGOS GEORGE AChief Executive OfficerFeb 10, 2015 Option Exercise$395.138,8713,505,19834,277Feb 11, 2015, 04:25 PM
SCANGOS GEORGE AChief Executive OfficerFeb 09, 2015 Option Exercise$396.884,9401,960,58724,315Feb 11, 2015, 04:25 PM
WILLIAMS DOUGLAS EEVP Research & DevelopmentFeb 08, 2015 Option Exercise$402.001,634656,86812,908Feb 10, 2015, 05:14 PM
ALEXANDER SUSAN HEVP, Chief Legal OfficerFeb 09, 2015 Option Exercise$396.881,842731,05325,874Feb 10, 2015, 05:12 PM
ALEXANDER SUSAN HEVP, Chief Legal OfficerFeb 08, 2015 Option Exercise$402.00818328,83623,807Feb 10, 2015, 05:12 PM
Sandrock AlfredGrp SVP, Chief Medical OfficerFeb 09, 2015 Option Exercise$396.88681270,27515,717Feb 10, 2015, 05:11 PM
Sandrock AlfredGrp SVP, Chief Medical OfficerFeb 08, 2015 Option Exercise$402.00421169,24215,430Feb 10, 2015, 05:11 PM
Sandrock AlfredGrp SVP, Chief Medical OfficerFeb 09, 2015 Sale$398.05856340,73114,574Feb 10, 2015, 05:11 PM
Holtzman Steven HEVP Corporate DevelopmentFeb 08, 2015 Option Exercise$402.001,275512,5504,527Feb 10, 2015, 05:10 PM
Kingsley Stuart AEVP, Global Comm. OperationsFeb 09, 2015 Option Exercise$396.88860341,3176,228Feb 10, 2015, 05:08 PM
Kingsley Stuart AEVP, Global Comm. OperationsFeb 08, 2015 Option Exercise$402.00883354,9665,264Feb 10, 2015, 05:08 PM
Cox JohnEVP Pharmaceutical Oper & TechFeb 09, 2015 Option Exercise$396.882,210877,10530,534Feb 10, 2015, 05:07 PM
Cox JohnEVP Pharmaceutical Oper & TechFeb 08, 2015 Option Exercise$402.001,537617,87428,053Feb 10, 2015, 05:07 PM
Clancy Paul JExecutive VP and CFOFeb 08, 2015 Option Exercise$402.001,143459,48617,503Feb 10, 2015, 05:06 PM
Clancy Paul JExecutive VP and CFOFeb 09, 2015 Option Exercise$396.882,210877,10519,984Feb 10, 2015, 05:06 PM
DiPietro KennethEVP Human ResourcesFeb 02, 2015 Sale$389.031,656644,2340Feb 03, 2015, 06:35 PM
DiPietro KennethEVP Human ResourcesFeb 01, 2015 Option Exercise$389.16807314,0521,656Feb 02, 2015, 07:46 PM
WILLIAMS DOUGLAS EEVP Research & DevelopmentFeb 01, 2015 Option Exercise$389.162,059801,28011,074Feb 02, 2015, 07:43 PM
Holtzman Steven HEVP Corporate DevelopmentFeb 01, 2015 Option Exercise$389.162,060801,6703,097Feb 02, 2015, 07:40 PM
Artavanis-Tsakonas SpyridonSVP, Chief Scientific OfficerDec 15, 2014 Sale$346.501,981686,417352Dec 16, 2014, 04:36 PM
Sandrock AlfredGrp SVP, Chief Medical OfficerDec 03, 2014 Option Exercise$347.34393136,50515,014Dec 05, 2014, 05:20 PM
Sandrock AlfredGrp SVP, Chief Medical OfficerDec 04, 2014 Sale$345.88440152,18714,574Dec 05, 2014, 05:20 PM
Holtzman Steven HEVP Corporate DevelopmentDec 02, 2014 Sale$335.651,749587,0520Dec 03, 2014, 04:32 PM
Holtzman Steven HEVP Corporate DevelopmentNov 11, 2014 Sale$330.001,750577,5001,749Nov 12, 2014, 04:24 PM
SCANGOS GEORGE AChief Executive OfficerNov 03, 2014 Sale$320.781,128361,84017,985Nov 04, 2014, 04:18 PM
SCANGOS GEORGE AChief Executive OfficerOct 01, 2014 Sale$330.971,127373,00319,113Oct 02, 2014, 04:44 PM
Holtzman Steven HEVP Corporate DevelopmentOct 01, 2014 Sale$330.971,750579,1983,499Oct 02, 2014, 04:42 PM
SCANGOS GEORGE AChief Executive OfficerSep 02, 2014 Sale$345.471,128389,69020,240Sep 04, 2014, 04:15 PM
SCANGOS GEORGE AChief Executive OfficerAug 01, 2014 Sale$332.931,128375,54521,368Aug 04, 2014, 04:43 PM
SCANGOS GEORGE AChief Executive OfficerJul 16, 2014 Sale$312.3712,3163,847,14922,496Jul 18, 2014, 05:59 PM
SCANGOS GEORGE AChief Executive OfficerJul 15, 2014 Option Exercise$312.0010,0623,139,34434,812Jul 17, 2014, 04:45 PM
Posner Brian SDirectorJun 20, 2014 Sale$315.00605190,5756,000Jun 23, 2014, 04:37 PM
Posner Brian SDirectorJun 13, 2014 Sale$310.50700217,3506,605Jun 16, 2014, 04:37 PM
SCANGOS GEORGE AChief Executive OfficerJun 02, 2014 Sale$318.93484154,36223,535Jun 03, 2014, 04:29 PM
Holtzman Steven HEVP Corporate DevelopmentMay 19, 2014 Sale$289.151,221353,0525,749May 20, 2014, 04:16 PM
SCANGOS GEORGE AChief Executive OfficerMay 01, 2014 Sale$285.562,123606,24125,656May 02, 2014, 04:22 PM
COVINO GREGORY FVP, Chief Accounting OfficerMay 01, 2014 Option Exercise$286.7511332,403916May 02, 2014, 04:20 PM
COVINO GREGORY FVP, Chief Accounting OfficerMay 01, 2014 Option Exercise$286.7534799,5021,029May 02, 2014, 04:20 PM
Holtzman Steven HEVP Corporate DevelopmentApr 17, 2014 Sale$291.001,221355,3116,970Apr 21, 2014, 05:07 PM
Artavanis-Tsakonas SpyridonSVP, Chief Scientific OfficerApr 02, 2014 Option Exercise$309.70433134,1002,244Apr 03, 2014, 04:27 PM
PANGIA ROBERT WDirectorApr 01, 2014 Option Exercise$47.556,250297,18720,253Apr 02, 2014, 04:19 PM
PANGIA ROBERT WDirectorApr 01, 2014 Sale$308.426,2501,927,62514,003Apr 02, 2014, 04:19 PM
SCANGOS GEORGE AChief Executive OfficerApr 01, 2014 Sale$308.422,123654,77626,142Apr 02, 2014, 04:16 PM
Posner Brian SDirectorMar 31, 2014 Sale$296.763,000890,2758,935Apr 01, 2014, 04:15 PM
DORSA CAROLINEDirectorMar 20, 2014 Option Exercise$53.6410,000536,40024,468Mar 21, 2014, 04:17 PM
DORSA CAROLINEDirectorMar 20, 2014 Sale$348.8810,0003,488,81222,268Mar 21, 2014, 04:17 PM
WILLIAMS DOUGLAS EEVP Research & DevelopmentMar 19, 2014 Sale$352.293,5051,234,7769,886Mar 21, 2014, 04:15 PM
Holtzman Steven HEVP Corporate DevelopmentMar 17, 2014 Sale$334.831,221408,8278,191Mar 18, 2014, 05:08 PM
SCANGOS GEORGE AChief Executive OfficerMar 10, 2014 Sale$333.7726,1248,719,37853,689Mar 12, 2014, 07:20 PM
LEAMING NANCYDirectorMar 10, 2014 Sale$327.652,000655,3007,660Mar 12, 2014, 07:16 PM
Kingsley Stuart AEVP, Global Comm. OperationsMar 11, 2014 Sale$336.838,4282,838,7669,054Mar 12, 2014, 07:15 PM
Sandrock AlfredGrp SVP, Chief Medical OfficerMar 04, 2014 Sale$342.583,1711,086,32115,407Mar 05, 2014, 03:12 PM
Sandrock AlfredGrp SVP, Chief Medical OfficerMar 03, 2014 Option Exercise$340.682,829963,78418,578Mar 04, 2014, 03:22 PM
SCANGOS GEORGE AChief Executive OfficerMar 03, 2014 Sale$335.792,942987,89456,368Mar 04, 2014, 03:19 PM
Sandrock AlfredGrp SVP, Chief Medical OfficerFeb 26, 2014 Sale$342.171,048358,59421,407Feb 27, 2014, 04:19 PM
Sandrock AlfredGrp SVP, Chief Medical OfficerFeb 23, 2014 Option Exercise$347.11940326,28322,455Feb 25, 2014, 02:21 PM
Cox JohnEVP Pharmaceutical Oper & TechFeb 23, 2014 Option Exercise$347.111,228426,25125,478Feb 25, 2014, 02:17 PM
Clancy Paul JExecutive VP and CFOFeb 23, 2014 Option Exercise$347.112,018700,46815,455Feb 25, 2014, 02:11 PM
ALEXANDER SUSAN HEVP, Chief Legal OfficerFeb 23, 2014 Option Exercise$347.111,803625,83922,127Feb 25, 2014, 02:07 PM
Holtzman Steven HEVP Corporate DevelopmentFeb 18, 2014 Sale$327.901,222400,6949,412Feb 19, 2014, 04:23 PM
WILLIAMS DOUGLAS EEVP Research & DevelopmentFeb 12, 2014 Option Exercise$323.041,685544,32211,481Feb 14, 2014, 04:48 PM
Clancy Paul JExecutive VP and CFOFeb 12, 2014 Option Exercise$323.041,324427,70513,193Feb 14, 2014, 04:46 PM
Artavanis-Tsakonas SpyridonSVP, Chief Scientific OfficerFeb 12, 2014 Option Exercise$323.0423977,2071,702Feb 14, 2014, 04:45 PM
ALEXANDER SUSAN HEVP, Chief Legal OfficerFeb 12, 2014 Option Exercise$323.041,010326,27020,109Feb 14, 2014, 04:43 PM
Sandrock AlfredGrp SVP, Chief Medical OfficerFeb 12, 2014 Option Exercise$323.04367118,55614,092Feb 14, 2014, 04:42 PM
Sandrock AlfredGrp SVP, Chief Medical OfficerFeb 13, 2014 Sale$316.42425134,47821,407Feb 14, 2014, 04:42 PM
Holtzman Steven HEVP Corporate DevelopmentFeb 12, 2014 Option Exercise$323.041,010326,27010,634Feb 14, 2014, 04:39 PM
COVINO GREGORY FVP, Chief Accounting OfficerFeb 12, 2014 Option Exercise$323.0482,584682Feb 14, 2014, 04:38 PM
SCANGOS GEORGE AChief Executive OfficerFeb 12, 2014 Option Exercise$323.044,3331,399,73257,817Feb 14, 2014, 04:37 PM
SCANGOS GEORGE AChief Executive OfficerFeb 13, 2014 Sale$316.81486153,97057,331Feb 14, 2014, 04:37 PM
DiPietro KennethEVP Human ResourcesFeb 12, 2014 Option Exercise$323.04956308,8261,290Feb 14, 2014, 04:36 PM
DiPietro KennethEVP Human ResourcesFeb 13, 2014 Sale$316.811,290408,6850Feb 14, 2014, 04:36 PM
Cox JohnEVP Pharmaceutical Oper & TechFeb 12, 2014 Option Exercise$323.041,059342,09924,108Feb 14, 2014, 04:34 PM
Sandrock AlfredGrp SVP, Chief Medical OfficerFeb 11, 2014 Sale$314.312,085655,33614,522Feb 12, 2014, 05:03 PM
SCANGOS GEORGE AChief Executive OfficerFeb 11, 2014 Sale$314.312,456771,94554,454Feb 12, 2014, 05:00 PM
SCANGOS GEORGE AChief Executive OfficerFeb 10, 2014 Option Exercise$315.548,8802,801,99555,417Feb 11, 2014, 07:55 PM
SCANGOS GEORGE AChief Executive OfficerFeb 09, 2014 Option Exercise$315.544,8501,530,36945,464Feb 11, 2014, 07:55 PM
Kingsley Stuart AEVP, Global Comm. OperationsFeb 09, 2014 Option Exercise$315.54861271,68010,752Feb 11, 2014, 07:52 PM
Kingsley Stuart AEVP, Global Comm. OperationsFeb 08, 2014 Option Exercise$315.541,243392,2169,789Feb 11, 2014, 07:52 PM
Clancy Paul JExecutive VP and CFOFeb 08, 2014 Option Exercise$315.541,047330,3709,231Feb 11, 2014, 07:49 PM
Clancy Paul JExecutive VP and CFOFeb 09, 2014 Option Exercise$315.542,212697,97411,710Feb 11, 2014, 07:49 PM
WILLIAMS DOUGLAS EEVP Research & DevelopmentFeb 08, 2014 Option Exercise$315.541,636516,2239,593Feb 11, 2014, 07:47 PM
Holtzman Steven HEVP Corporate DevelopmentFeb 08, 2014 Option Exercise$315.541,276402,6299,502Feb 11, 2014, 07:45 PM
Sandrock AlfredGrp SVP, Chief Medical OfficerFeb 09, 2014 Option Exercise$315.54594187,43115,752Feb 11, 2014, 07:43 PM
Sandrock AlfredGrp SVP, Chief Medical OfficerFeb 08, 2014 Option Exercise$315.54422133,15814,522Feb 11, 2014, 07:43 PM
ALEXANDER SUSAN HEVP, Chief Legal OfficerFeb 09, 2014 Option Exercise$315.541,746550,93318,977Feb 11, 2014, 06:07 PM
ALEXANDER SUSAN HEVP, Chief Legal OfficerFeb 08, 2014 Option Exercise$315.54819258,42716,814Feb 11, 2014, 06:07 PM
Cox JohnEVP Pharmaceutical Oper & TechFeb 09, 2014 Option Exercise$315.542,212697,97422,921Feb 11, 2014, 06:07 PM
Cox JohnEVP Pharmaceutical Oper & TechFeb 08, 2014 Option Exercise$315.541,441454,69320,442Feb 11, 2014, 06:07 PM
DiPietro KennethEVP Human ResourcesFeb 04, 2014 Sale$299.011,655494,8620Feb 05, 2014, 04:36 PM
DiPietro KennethEVP Human ResourcesFeb 01, 2014 Option Exercise$312.64808252,6131,655Feb 03, 2014, 05:29 PM
WILLIAMS DOUGLAS EEVP Research & DevelopmentFeb 01, 2014 Option Exercise$312.641,969615,5887,761Feb 03, 2014, 05:25 PM
Kingsley Stuart AEVP, Global Comm. OperationsFeb 01, 2014 Option Exercise$312.641,701531,8018,396Feb 03, 2014, 05:20 PM
Holtzman Steven HEVP Corporate DevelopmentFeb 01, 2014 Option Exercise$312.641,971616,2138,073Feb 03, 2014, 05:15 PM
Rowinsky Eric KDirectorJan 21, 2014 Sale$310.092,020626,38210,440Jan 22, 2014, 04:49 PM
SCHENK LYNNDirectorJan 15, 2014 Sale$297.481,000297,4803,100Jan 16, 2014, 10:27 AM
YOUNG WILLIAMDirectorJan 08, 2014 Sale$285.1115,0004,276,59018,509Jan 09, 2014, 04:24 PM
PANGIA ROBERT WDirectorJan 06, 2014 Option Exercise$47.556,250297,18720,253Jan 07, 2014, 12:22 PM
PANGIA ROBERT WDirectorJan 06, 2014 Sale$278.036,2501,737,68714,003Jan 07, 2014, 12:22 PM
SHERWIN STEPHEN ADirectorJan 02, 2014 Option Exercise$59.825,500329,0109,460Jan 06, 2014, 11:19 AM
SHERWIN STEPHEN ADirectorJan 02, 2014 Sale$279.285,5001,536,0597,660Jan 06, 2014, 11:19 AM
Sandrock AlfredGrp SVP, Chief Medical OfficerDec 03, 2013 Option Exercise$287.76394113,37714,106Dec 05, 2013, 02:53 PM
Sandrock AlfredGrp SVP, Chief Medical OfficerDec 04, 2013 Sale$285.90439125,51013,667Dec 05, 2013, 02:53 PM
SCHENK LYNNDirectorDec 02, 2013 Sale$291.711,000291,7104,100Dec 02, 2013, 03:28 PM
Pawlicki RaymondSVP, Chief Information OfficerNov 22, 2013 Option Exercise$49.954,000199,80012,710Nov 25, 2013, 02:11 PM
Pawlicki RaymondSVP, Chief Information OfficerNov 22, 2013 Sale$288.004,0001,152,0008,710Nov 25, 2013, 02:11 PM
SCHENK LYNNDirectorNov 01, 2013 Sale$245.001,000245,0005,100Nov 05, 2013, 12:18 PM
SCANGOS GEORGE AChief Executive OfficerNov 01, 2013 Sale$245.572,239549,83140,156Nov 05, 2013, 12:13 PM
Sandrock AlfredGrp SVP, Chief Medical OfficerOct 22, 2013 Option Exercise$60.5615,030910,21729,530Oct 23, 2013, 05:03 PM
Sandrock AlfredGrp SVP, Chief Medical OfficerOct 22, 2013 Sale$250.1115,0303,759,12314,500Oct 23, 2013, 05:03 PM
SCHENK LYNNDirectorOct 01, 2013 Sale$242.851,000242,8506,100Oct 02, 2013, 05:09 PM
SCANGOS GEORGE AChief Executive OfficerOct 01, 2013 Sale$242.852,239543,74142,395Oct 02, 2013, 04:35 PM
DiPietro KennethEVP Human ResourcesSep 30, 2013 Sale$242.001,440348,4800Oct 02, 2013, 01:36 PM
Clancy Paul JExecutive VP and CFOSep 18, 2013 Option Exercise$49.6526,7851,329,87533,872Sep 19, 2013, 02:14 PM
Clancy Paul JExecutive VP and CFOSep 18, 2013 Sale$245.0026,7856,562,3257,087Sep 19, 2013, 02:14 PM
Clancy Paul JExecutive VP and CFOSep 16, 2013 Option Exercise$56.1199,0305,556,89551,027Sep 18, 2013, 04:34 PM
Clancy Paul JExecutive VP and CFOSep 16, 2013 Sale$238.2799,03023,596,31142,027Sep 18, 2013, 04:34 PM
Holtzman Steven HEVP Corporate DevelopmentSep 17, 2013 Sale$238.983,501836,6694,885Sep 18, 2013, 04:31 PM
Sandrock AlfredGrp SVP, Chief Medical OfficerSep 16, 2013 Option Exercise$49.659,820487,56324,320Sep 18, 2013, 04:28 PM
Sandrock AlfredGrp SVP, Chief Medical OfficerSep 16, 2013 Sale$240.109,8202,357,82114,500Sep 18, 2013, 04:28 PM
Pawlicki RaymondSVP, Chief Information OfficerSep 16, 2013 Option Exercise$49.594,000198,36012,710Sep 18, 2013, 04:26 PM
Pawlicki RaymondSVP, Chief Information OfficerSep 16, 2013 Sale$238.034,000952,1208,710Sep 18, 2013, 04:26 PM
SCHENK LYNNDirectorSep 11, 2013 Sale$235.25900211,7263,325Sep 13, 2013, 02:33 PM
SCANGOS GEORGE AChief Executive OfficerSep 03, 2013 Sale$214.402,239480,04245,534Sep 04, 2013, 04:52 PM
WILLIAMS DOUGLAS EEVP Research & DevelopmentAug 26, 2013 Sale$211.354,368923,1684,571Aug 28, 2013, 12:30 PM
SCANGOS GEORGE AChief Executive OfficerAug 01, 2013 Sale$218.822,239489,93845,761Aug 02, 2013, 10:55 AM
SCANGOS GEORGE AChief Executive OfficerJul 16, 2013 Sale$223.942,239501,40248,000Jul 18, 2013, 11:24 AM
SCANGOS GEORGE AChief Executive OfficerJul 15, 2013 Option Exercise$224.3320,0114,489,06860,177Jul 16, 2013, 06:19 PM
DENNER ALEXANDER JDirectorJun 14, 2013 Sale$212.002,900614,8006,325Jun 17, 2013, 03:46 PM
PAPADOPOULOS STELIOSDirectorJun 11, 2013 Sale$219.622,020443,63212,930Jun 13, 2013, 04:27 PM
Posner Brian SDirectorJun 11, 2013 Sale$219.622,020443,6328,130Jun 13, 2013, 04:23 PM
SCHENK LYNNDirectorJun 10, 2013 Sale$225.822,000451,6333,920Jun 11, 2013, 03:55 PM
SCANGOS GEORGE AChief Executive OfficerJun 03, 2013 Sale$234.161,598374,18848,911Jun 04, 2013, 03:29 PM
SHERWIN STEPHEN ADirectorJun 03, 2013 Option Exercise$59.8212,825767,19115,480Jun 04, 2013, 03:26 PM
SHERWIN STEPHEN ADirectorJun 03, 2013 Sale$233.2612,8252,991,60512,047Jun 04, 2013, 03:26 PM
Mulligan RichardDirectorMay 29, 2013 Option Exercise$53.433,000160,2905,020May 31, 2013, 12:27 PM
DENNER ALEXANDER JDirectorMay 29, 2013 Option Exercise$53.433,000160,2907,920May 31, 2013, 12:26 PM
Mulligan RichardDirectorMay 28, 2013 Option Exercise$53.4337,9752,029,00437,020May 29, 2013, 05:16 PM
Mulligan RichardDirectorMay 28, 2013 Sale$240.6937,9759,140,10036,120May 29, 2013, 05:16 PM
DENNER ALEXANDER JDirectorMay 28, 2013 Option Exercise$53.4337,9752,029,00439,920May 29, 2013, 05:15 PM
DENNER ALEXANDER JDirectorMay 28, 2013 Sale$240.5737,9759,135,69737,620May 29, 2013, 05:15 PM
PANGIA ROBERT WDirectorMay 28, 2013 Sale$237.235,9001,399,65712,698May 29, 2013, 05:12 PM
Pawlicki RaymondSVP, Chief Information OfficerMay 03, 2013 Option Exercise$218.85866189,5248,710May 07, 2013, 01:36 PM
Cox JohnEVP Pharmaceutical Oper & TechMay 03, 2013 Option Exercise$218.85866189,52418,060May 07, 2013, 01:33 PM
COVINO GREGORY FVP, Chief Accounting OfficerMay 01, 2013 Option Exercise$214.3311424,434375May 03, 2013, 03:10 PM
SCANGOS GEORGE AChief Executive OfficerMay 01, 2013 Sale$215.391,598344,19350,509May 03, 2013, 03:07 PM
Clancy Paul JExecutive VP and CFOApr 30, 2013 Sale$224.6614,4893,255,09019,608May 01, 2013, 03:45 PM
Clancy Paul JExecutive VP and CFOApr 29, 2013 Sale$219.719,1232,004,41421,576May 01, 2013, 03:45 PM
SCANGOS GEORGE AChief Executive OfficerApr 01, 2013 Sale$193.661,598309,46952,107Apr 03, 2013, 12:31 PM
SCANGOS GEORGE AChief Executive OfficerApr 01, 2013 Sale$193.661,598309,46952,107Apr 02, 2013, 01:23 PM
Mulligan RichardDirectorMar 22, 2013 Sale$176.882,900512,9522,020Mar 25, 2013, 02:20 PM
SHERWIN STEPHEN ADirectorMar 22, 2013 Sale$176.881,500265,3202,655Mar 25, 2013, 02:18 PM
Posner Brian SDirectorMar 18, 2013 Sale$174.814,500786,64510,150Mar 19, 2013, 03:15 PM
Mulligan RichardDirectorMar 13, 2013 Sale$175.387,9801,399,5309,920Mar 13, 2013, 02:56 PM
PAPADOPOULOS STELIOSDirectorMar 11, 2013 Option Exercise$58.4446,6752,727,46349,950Mar 12, 2013, 02:22 PM
PAPADOPOULOS STELIOSDirectorMar 11, 2013 Sale$172.2646,6758,040,00318,916Mar 12, 2013, 02:22 PM
Pawlicki RaymondSVP, Chief Information OfficerMar 01, 2013 Option Exercise$168.70630106,2819,410Mar 04, 2013, 04:42 PM
SCANGOS GEORGE AChief Executive OfficerMar 01, 2013 Sale$165.301,598264,14953,705Mar 04, 2013, 04:40 PM
Cox JohnEVP Pharmaceutical Oper & TechFeb 23, 2013 Option Exercise$164.401,227201,71918,759Feb 26, 2013, 01:26 PM
ALEXANDER SUSAN HEVP, Chief Legal OfficerFeb 23, 2013 Option Exercise$164.401,803296,41315,135Feb 26, 2013, 01:25 PM
Pawlicki RaymondSVP, Chief Information OfficerFeb 23, 2013 Option Exercise$164.40722118,69710,040Feb 26, 2013, 01:24 PM
Clancy Paul JExecutive VP and CFOFeb 23, 2013 Option Exercise$164.402,021332,25230,699Feb 26, 2013, 01:23 PM
SCANGOS GEORGE AChief Executive OfficerFeb 13, 2013 Sale$163.391,598261,09755,303Feb 14, 2013, 02:59 PM
Kingsley Stuart AEVP, Global Comm. OperationsFeb 09, 2013 Option Exercise$164.44861141,5835,511Feb 12, 2013, 05:26 PM
Kingsley Stuart AEVP, Global Comm. OperationsFeb 08, 2013 Option Exercise$164.44831136,6504,548Feb 12, 2013, 05:26 PM
Clancy Paul JExecutive VP and CFOFeb 09, 2013 Option Exercise$164.441,731284,64628,439Feb 12, 2013, 05:24 PM
Clancy Paul JExecutive VP and CFOFeb 08, 2013 Option Exercise$164.44899147,83225,478Feb 12, 2013, 05:24 PM
Holtzman Steven HEVP Corporate DevelopmentFeb 08, 2013 Option Exercise$164.44940154,5748,386Feb 12, 2013, 05:22 PM
Pawlicki RaymondSVP, Chief Information OfficerFeb 09, 2013 Option Exercise$164.44893146,8459,233Feb 12, 2013, 05:20 PM
Pawlicki RaymondSVP, Chief Information OfficerFeb 08, 2013 Option Exercise$164.4452386,0028,236Feb 12, 2013, 05:20 PM
ALEXANDER SUSAN HEVP, General CounselFeb 09, 2013 Option Exercise$164.441,275209,66113,117Feb 12, 2013, 05:12 PM
ALEXANDER SUSAN HEVP, General CounselFeb 08, 2013 Option Exercise$164.44702115,43710,483Feb 12, 2013, 05:12 PM
Cox JohnEVP Pharmaceutical Oper & TechFeb 09, 2013 Option Exercise$164.441,836301,91217,388Feb 12, 2013, 05:10 PM
Cox JohnEVP Pharmaceutical Oper & TechFeb 08, 2013 Option Exercise$164.441,133186,31114,532Feb 12, 2013, 05:10 PM
WILLIAMS DOUGLAS EEVP Research & DevelopmentFeb 08, 2013 Option Exercise$164.441,252205,8798,939Feb 12, 2013, 05:08 PM
SCANGOS GEORGE AChief Executive OfficerFeb 10, 2013 Option Exercise$164.448,8901,461,87256,901Feb 12, 2013, 05:05 PM
SCANGOS GEORGE AChief Executive OfficerFeb 09, 2013 Option Exercise$164.443,723612,21046,958Feb 12, 2013, 05:05 PM
PANGIA ROBERT WDirectorFeb 06, 2013 Option Exercise$66.292,500165,72521,098Feb 07, 2013, 01:58 PM
PANGIA ROBERT WDirectorFeb 06, 2013 Sale$165.552,500413,87518,598Feb 07, 2013, 01:58 PM
Pawlicki RaymondSVP, Chief Information OfficerFeb 06, 2013 Option Exercise$49.6510,000496,50017,653Feb 07, 2013, 01:55 PM
Pawlicki RaymondSVP, Chief Information OfficerFeb 06, 2013 Sale$165.5510,0001,655,5007,653Feb 07, 2013, 01:55 PM
WILLIAMS DOUGLAS EEVP Research & DevelopmentFeb 01, 2013 Option Exercise$157.301,679264,1077,185Feb 05, 2013, 06:23 PM
Holtzman Steven HEVP Corporate DevelopmentFeb 01, 2013 Option Exercise$157.301,678263,9496,982Feb 05, 2013, 04:25 PM
DiPietro KennethEVP Human ResourcesFeb 01, 2013 Option Exercise$157.30711111,8401,440Feb 05, 2013, 04:23 PM
Kingsley Stuart AEVP, Global Comm. OperationsFeb 01, 2013 Option Exercise$157.301,491234,5343,095Feb 05, 2013, 04:22 PM
DENNER ALEXANDER JDirectorDec 27, 2012 Sale$148.363,991592,0866,220Dec 28, 2012, 10:15 AM
DENNER ALEXANDER JDirectorDec 26, 2012 Sale$148.893,989593,9148,911Dec 28, 2012, 10:15 AM
SCANGOS GEORGE AChief Executive OfficerNov 01, 2012 Sale$139.422,472344,64052,898Nov 02, 2012, 03:49 PM
SCANGOS GEORGE AChief Executive OfficerOct 01, 2012 Sale$149.163,654545,03154,142Oct 02, 2012, 01:10 PM
PANGIA ROBERT WDirectorSep 17, 2012 Option Exercise$66.295,000331,45023,598Sep 18, 2012, 05:26 PM
PANGIA ROBERT WDirectorSep 17, 2012 Sale$155.005,000775,00018,598Sep 18, 2012, 05:26 PM
PANGIA ROBERT WDirectorSep 06, 2012 Option Exercise$66.295,000331,45023,598Sep 10, 2012, 02:20 PM
PANGIA ROBERT WDirectorSep 06, 2012 Sale$150.005,000750,00018,598Sep 10, 2012, 02:20 PM
SHERWIN STEPHEN ADirectorSep 04, 2012 Sale$145.902,000291,8004,155Sep 05, 2012, 03:20 PM
SCANGOS GEORGE AChief Executive OfficerSep 04, 2012 Sale$145.903,654533,11957,796Sep 05, 2012, 03:17 PM
ALEXANDER SUSAN HEVP, General CounselAug 02, 2012 Sale$142.991,165166,5839,020Aug 03, 2012, 11:12 AM
SCANGOS GEORGE AChief Executive OfficerAug 01, 2012 Sale$146.303,655534,72761,450Aug 02, 2012, 03:24 PM
ALEXANDER SUSAN HEVP, General CounselJul 27, 2012 Option Exercise$57.0458,0703,312,15768,255Jul 30, 2012, 02:58 PM
ALEXANDER SUSAN HEVP, General CounselJul 27, 2012 Sale$150.0058,0708,710,50010,185Jul 30, 2012, 02:58 PM
SCANGOS GEORGE AChief Executive OfficerJul 17, 2012 Sale$146.042,472361,01166,333Jul 18, 2012, 03:35 PM
SCANGOS GEORGE AChief Executive OfficerJul 16, 2012 Option Exercise$144.6117,6792,556,56076,357Jul 17, 2012, 01:03 PM
SCANGOS GEORGE AChief Executive OfficerJul 02, 2012 Sale$143.501,183169,76163,917Jul 03, 2012, 10:40 AM
Pawlicki RaymondSVP, Chief Information OfficerJun 19, 2012 Option Exercise$49.5910,000495,90017,653Jun 21, 2012, 11:41 AM
Pawlicki RaymondSVP, Chief Information OfficerJun 19, 2012 Sale$143.0010,0001,430,0007,653Jun 21, 2012, 11:41 AM
ALEXANDER SUSAN HEVP, General CounselJun 15, 2012 Option Exercise$47.8749,8002,383,83859,985Jun 18, 2012, 01:53 PM
ALEXANDER SUSAN HEVP, General CounselJun 15, 2012 Sale$140.0049,8006,972,00010,185Jun 18, 2012, 01:53 PM
PANGIA ROBERT WDirectorJun 15, 2012 Option Exercise$36.945,000184,70023,598Jun 18, 2012, 01:50 PM
PANGIA ROBERT WDirectorJun 15, 2012 Sale$140.005,000700,00018,598Jun 18, 2012, 01:50 PM
Posner Brian SDirectorJun 07, 2012 Option Exercise$71.382,500178,45015,130Jun 11, 2012, 11:22 AM
Posner Brian SDirectorJun 07, 2012 Sale$135.002,500337,50012,630Jun 11, 2012, 11:22 AM
PANGIA ROBERT WDirectorJun 04, 2012 Option Exercise$36.945,000184,70021,578Jun 05, 2012, 03:45 PM
PANGIA ROBERT WDirectorJun 04, 2012 Sale$130.005,000650,00016,578Jun 05, 2012, 03:45 PM
SHERWIN STEPHEN ADirectorJun 04, 2012 Sale$126.452,500316,1254,135Jun 05, 2012, 03:43 PM
Posner Brian SDirectorJun 04, 2012 Option Exercise$71.382,400171,31215,030Jun 05, 2012, 03:41 PM
Posner Brian SDirectorJun 04, 2012 Sale$126.452,400303,48012,630Jun 05, 2012, 03:41 PM
Pawlicki RaymondSVP, Chief Information OfficerJun 04, 2012 Sale$126.451,068135,0497,653Jun 05, 2012, 03:39 PM
SCANGOS GEORGE AChief Executive OfficerJun 01, 2012 Sale$128.631,183152,16965,100Jun 04, 2012, 04:26 PM
Cox JohnEVP Pharmaceutical Oper & TechMay 03, 2012 Option Exercise$134.26765102,70912,178May 04, 2012, 02:03 PM
Pawlicki RaymondSVP, Chief Information OfficerMay 03, 2012 Option Exercise$134.26765102,7098,721May 04, 2012, 02:02 PM
SCHENK LYNNDirectorMay 02, 2012 Option Exercise$53.435,975319,2448,875May 03, 2012, 04:46 PM
SCHENK LYNNDirectorMay 02, 2012 Sale$135.005,975806,6252,900May 03, 2012, 04:46 PM
SCHENK LYNNDirectorMay 02, 2012 Sale$135.008,4801,144,8007,100May 03, 2012, 04:46 PM
ALEXANDER SUSAN HEVP, General CounselMay 02, 2012 Option Exercise$44.7320,000894,60030,185May 03, 2012, 04:34 PM
ALEXANDER SUSAN HEVP, General CounselMay 02, 2012 Sale$135.0020,0002,700,00010,185May 03, 2012, 04:34 PM
ALEXANDER SUSAN HEVP, General CounselApr 25, 2012 Option Exercise$44.7316,764749,85426,949Apr 26, 2012, 03:44 PM
ALEXANDER SUSAN HEVP, General CounselApr 25, 2012 Sale$130.0016,7642,179,32010,185Apr 26, 2012, 03:44 PM
ALEXANDER SUSAN HEVP, General CounselApr 04, 2012 Option Exercise$44.733,236144,74613,421Apr 06, 2012, 03:28 PM
ALEXANDER SUSAN HEVP, General CounselApr 04, 2012 Sale$130.003,236420,68010,185Apr 06, 2012, 03:28 PM
PANGIA ROBERT WDirectorMar 08, 2012 Option Exercise$35.217,500264,05021,578Mar 12, 2012, 03:02 PM
PANGIA ROBERT WDirectorMar 08, 2012 Sale$120.007,500900,00016,578Mar 12, 2012, 03:02 PM
Gagnon Robert E.Vice President, FinanceFeb 29, 2012 Sale$115.5171782,8214,356Mar 01, 2012, 03:23 PM
Gagnon Robert E.Vice President, FinanceFeb 28, 2012 Sale$115.0383596,0504,716Mar 01, 2012, 03:23 PM
ALEXANDER SUSAN HEVP, General CounselFeb 27, 2012 Sale$115.434,255491,15512,302Feb 28, 2012, 04:01 PM
ALEXANDER SUSAN HEVP, General CounselFeb 23, 2012 Option Exercise$116.701,413164,89719,186Feb 27, 2012, 04:20 PM
ALEXANDER SUSAN HEVP, General CounselFeb 24, 2012 Option Exercise$116.392,601302,73015,747Feb 27, 2012, 04:20 PM
ALEXANDER SUSAN HEVP, General CounselFeb 24, 2012 Sale$115.532,145247,81217,447Feb 27, 2012, 04:20 PM
Cox JohnEVP Pharmaceutical Oper & TechFeb 24, 2012 Option Exercise$116.391,578183,66313,506Feb 27, 2012, 04:19 PM
Cox JohnEVP Pharmaceutical Oper & TechFeb 23, 2012 Option Exercise$116.701,085126,61914,291Feb 27, 2012, 04:19 PM
Gagnon Robert E.Vice President, FinanceFeb 23, 2012 Option Exercise$116.7038845,2805,885Feb 27, 2012, 04:18 PM
Gagnon Robert E.Vice President, FinanceFeb 24, 2012 Option Exercise$116.3933438,8745,719Feb 27, 2012, 04:18 PM
Gagnon Robert E.Vice President, FinanceFeb 24, 2012 Option Exercise$49.651,05452,3316,939Feb 27, 2012, 04:18 PM
Gagnon Robert E.Vice President, FinanceFeb 24, 2012 Sale$115.531,054121,7695,885Feb 27, 2012, 04:18 PM
Clancy Paul JExecutive VP and CFOFeb 24, 2012 Option Exercise$116.392,786324,26325,012Feb 27, 2012, 04:17 PM
Clancy Paul JExecutive VP and CFOFeb 23, 2012 Option Exercise$116.701,786208,42626,398Feb 27, 2012, 04:17 PM
SCANGOS GEORGE AChief Executive OfficerJul 15, 2011 Option Exercise$104.008,791914,26454,374Feb 22, 2012, 12:03 PM
Kingsley Stuart AEVP, Global Comm. OperationsFeb 14, 2012 Sale$118.611,247147,9070Feb 16, 2012, 02:39 PM
Gagnon Robert E.Vice President, FinanceFeb 14, 2012 Sale$118.6156066,4225,050Feb 16, 2012, 02:37 PM
ALEXANDER SUSAN HEVP, General CounselFeb 13, 2012 Sale$118.012,842335,38416,777Feb 14, 2012, 03:58 PM
Kingsley Stuart AEVP, Global Comm. OperationsFeb 09, 2012 Option Exercise$117.7857968,1951,247Feb 14, 2012, 03:57 PM
Cox JohnEVP Pharmaceutical Oper & TechFeb 09, 2012 Option Exercise$117.781,504177,14112,776Feb 13, 2012, 04:28 PM
Gagnon Robert E.Vice President, FinanceFeb 09, 2012 Option Exercise$117.7830135,4525,610Feb 13, 2012, 04:27 PM
ALEXANDER SUSAN HEVP, General CounselFeb 09, 2012 Option Exercise$117.781,257148,04919,619Feb 13, 2012, 04:26 PM
SCANGOS GEORGE AChief Executive OfficerFeb 10, 2012 Option Exercise$118.147,007827,80766,283Feb 13, 2012, 04:24 PM
Clancy Paul JExecutive VP and CFOFeb 09, 2012 Option Exercise$117.781,957230,49523,903Feb 13, 2012, 04:21 PM
Kingsley Stuart AEVP, Global Comm. OperationsFeb 06, 2012 Sale$121.033,110376,4030Feb 08, 2012, 03:07 PM
Clancy Paul JExecutive VP and CFOFeb 01, 2012 Option Exercise$52.9521,4001,133,08842,568Feb 03, 2012, 02:56 PM
Clancy Paul JExecutive VP and CFOFeb 01, 2012 Sale$120.0021,4002,568,00029,568Feb 03, 2012, 02:56 PM
WILLIAMS DOUGLAS EEVP Research & DevelopmentFeb 01, 2012 Option Exercise$121.261,656200,8073,906Feb 03, 2012, 02:55 PM
Holtzman Steven HEVP Corp Devel and StrategyFeb 01, 2012 Option Exercise$121.261,658201,0493,501Feb 03, 2012, 02:54 PM
Granata FrancescoEVP Global Commercial OperatioFeb 01, 2012 Option Exercise$121.261,669202,3833,529Feb 03, 2012, 02:53 PM
Kingsley Stuart AEVP, Global Comm. OperationsFeb 01, 2012 Option Exercise$121.261,477179,1013,110Feb 03, 2012, 02:52 PM
LEAMING NANCYDirectorFeb 01, 2012 Option Exercise$59.175,700337,26912,035Feb 03, 2012, 02:51 PM
LEAMING NANCYDirectorFeb 01, 2012 Sale$120.005,700684,0006,335Feb 03, 2012, 02:51 PM
LEAMING NANCYDirectorJan 20, 2012 Option Exercise$55.973,000167,9109,335Jan 24, 2012, 03:55 PM
LEAMING NANCYDirectorJan 20, 2012 Sale$118.003,000354,0006,335Jan 24, 2012, 03:55 PM
LEAMING NANCYDirectorJan 06, 2012 Option Exercise$55.973,000167,9109,335Jan 09, 2012, 03:54 PM
LEAMING NANCYDirectorJan 06, 2012 Sale$116.003,000348,0006,335Jan 09, 2012, 03:54 PM
Rowinsky Eric KDirectorJan 06, 2012 Option Exercise$59.8212,992777,18120,802Jan 09, 2012, 03:52 PM
Rowinsky Eric KDirectorJan 06, 2012 Sale$116.0012,9921,507,0729,135Jan 09, 2012, 03:52 PM
LEAMING NANCYDirectorJan 03, 2012 Option Exercise$55.974,000223,88010,335Jan 04, 2012, 01:27 PM
LEAMING NANCYDirectorJan 03, 2012 Sale$114.004,000456,0006,335Jan 04, 2012, 01:27 PM
Clancy Paul JExecutive VP and CFOJan 03, 2012 Sale$112.3520,2442,274,39826,742Jan 04, 2012, 01:24 PM
SHERWIN STEPHEN ADirectorDec 19, 2011 Sale$110.882,500277,2006,635Dec 20, 2011, 03:10 PM
Gagnon Robert E.Chief Acct Officer VP & ContrDec 06, 2011 Sale$112.3179589,2865,050Dec 08, 2011, 02:05 PM
Gagnon Robert E.Chief Acct Officer VP & ContrDec 01, 2011 Option Exercise$116.4837143,2145,845Dec 02, 2011, 02:10 PM
Gagnon Robert E.Chief Acct Officer VP & ContrNov 09, 2011 Sale$112.0479689,1846,216Nov 14, 2011, 11:26 AM
Gagnon Robert E.Chief Acct Officer VP & ContrNov 02, 2011 Option Exercise$113.4337142,0837,012Nov 04, 2011, 11:50 AM
Cox JohnEVP Pharmaceutical Oper & TechNov 01, 2011 Option Exercise$72.872,175158,49211,763Nov 03, 2011, 10:52 AM
Cox JohnEVP Pharmaceutical Oper & TechNov 01, 2011 Sale$114.372,175248,7559,588Nov 03, 2011, 10:52 AM
Gagnon Robert E.Chief Acct Officer VP & ContrOct 05, 2011 Sale$97.6625224,6107,383Oct 07, 2011, 01:48 PM
Gagnon Robert E.Chief Acct Officer VP & ContrOct 01, 2011 Option Exercise$93.1511810,9927,635Oct 04, 2011, 06:28 PM
Gagnon Robert E.Chief Acct Officer VP & ContrOct 03, 2011 Option Exercise$49.5977838,5818,413Oct 04, 2011, 06:28 PM
Gagnon Robert E.Chief Acct Officer VP & ContrOct 03, 2011 Sale$92.5577872,0047,635Oct 04, 2011, 06:28 PM
YOUNG WILLIAMDirectorSep 27, 2011 Option Exercise$51.3833,2501,708,44160,109Sep 29, 2011, 01:01 PM
YOUNG WILLIAMDirectorSep 27, 2011 Sale$96.1433,2503,196,65526,859Sep 29, 2011, 01:01 PM
LEAMING NANCYDirectorSep 16, 2011 Sale$100.003,085308,5006,335Sep 19, 2011, 05:18 PM
YOUNG WILLIAMDirectorSep 01, 2011 Option Exercise$46.6835,0001,633,77561,859Sep 02, 2011, 12:45 PM
YOUNG WILLIAMDirectorSep 01, 2011 Sale$95.0035,0003,325,00026,859Sep 02, 2011, 12:45 PM
Posner Brian SDirectorAug 29, 2011 Option Exercise$71.3815,0001,070,70027,630Aug 31, 2011, 11:44 AM
Posner Brian SDirectorAug 29, 2011 Sale$92.5315,0001,387,89412,630Aug 31, 2011, 11:44 AM
YOUNG WILLIAMDirectorAug 29, 2011 Option Exercise$68.1510,000681,50036,859Aug 31, 2011, 11:42 AM
YOUNG WILLIAMDirectorAug 29, 2011 Sale$92.5810,000925,78426,859Aug 31, 2011, 11:42 AM
ALEXANDER SUSAN HEVP, General CounselAug 01, 2011 Option Exercise$102.9083585,92218,130Aug 03, 2011, 11:24 AM
ALEXANDER SUSAN HEVP, General CounselAug 02, 2011 Sale$102.041,165118,87716,965Aug 03, 2011, 11:24 AM
Clancy Paul JExecutive VP and CFOAug 01, 2011 Option Exercise$102.9083585,92241,412Aug 03, 2011, 11:23 AM
SCANGOS GEORGE AChief Executive OfficerJul 20, 2011 Sale$106.5112,3471,315,03564,164Jul 21, 2011, 02:30 PM
SCANGOS GEORGE AChief Executive OfficerJul 15, 2011 Option Exercise$104.008,911926,74466,804Jul 19, 2011, 04:29 PM
SCANGOS GEORGE AChief Executive OfficerJul 14, 2011 Option Exercise$104.008,791914,26454,374Jul 19, 2011, 04:29 PM
Granata FrancescoEVP Global Commercial OperatioJul 01, 2011 Sale$107.522,901311,9180Jul 01, 2011, 01:51 PM
LEAMING NANCYDirectorJun 14, 2011 Sale$92.622,300213,0229,420Jun 14, 2011, 05:20 PM
Posner Brian SDirectorMay 25, 2011 Option Exercise$67.2525,9751,746,84435,705May 27, 2011, 03:15 PM
Posner Brian SDirectorMay 25, 2011 Sale$94.0925,9752,444,02722,900May 27, 2011, 03:15 PM
LEAMING NANCYDirectorMay 26, 2011 Option Exercise$55.5133,1751,841,62841,995May 27, 2011, 03:13 PM
LEAMING NANCYDirectorMay 26, 2011 Sale$93.0533,1753,087,08513,451May 27, 2011, 03:13 PM
PANGIA ROBERT WDirectorMay 26, 2011 Option Exercise$56.8815,000853,20029,080May 27, 2011, 03:11 PM
PANGIA ROBERT WDirectorMay 26, 2011 Sale$93.1115,0001,396,64716,280May 27, 2011, 03:11 PM
Gagnon Robert E.Chief Acct Officer VP & ContrMay 06, 2011 Sale$96.1396792,9607,753May 09, 2011, 04:38 PM
Gagnon Robert E.Chief Acct Officer VP & ContrMay 03, 2011 Option Exercise$97.9945044,0958,935May 04, 2011, 02:53 PM
Gagnon Robert E.Chief Acct Officer VP & ContrMay 04, 2011 Sale$96.0321520,6468,720May 04, 2011, 02:53 PM
Cox JohnEVP Pharmaceutical Oper & TechMay 03, 2011 Option Exercise$97.9976574,9629,588May 04, 2011, 02:51 PM
Gagnon Robert E.Chief Acct Officer VP & ContrMay 01, 2011 Option Exercise$97.651019,8639,385May 03, 2011, 01:03 PM
ALEXANDER SUSAN HEVP, General CounselMay 02, 2011 Sale$97.2020,9932,040,49735,834May 03, 2011, 01:01 PM
Clancy Paul JExecutive VP and CFOApr 28, 2011 Option Exercise$41.1814,766608,11957,202Apr 29, 2011, 03:03 PM
Clancy Paul JExecutive VP and CFOApr 28, 2011 Sale$98.9119,7161,950,08848,497Apr 29, 2011, 03:03 PM
Cox JohnEVP Pharmaceutical Oper & TechApr 21, 2011 Option Exercise$72.874,350316,98514,703Apr 25, 2011, 02:02 PM
Cox JohnEVP Pharmaceutical Oper & TechApr 21, 2011 Sale$100.004,350435,00010,353Apr 25, 2011, 02:02 PM
SCHENK LYNNDirectorApr 20, 2011 Option Exercise$61.8437,2752,304,94735,255Apr 21, 2011, 04:41 PM
SCHENK LYNNDirectorApr 20, 2011 Sale$85.2237,2753,176,4617,980Apr 21, 2011, 04:41 PM
Cox JohnEVP Pharmaceutical Oper & TechApr 13, 2011 Option Exercise$56.7336,2342,055,64646,587Apr 15, 2011, 11:50 AM
Cox JohnEVP Pharmaceutical Oper & TechApr 13, 2011 Sale$80.0036,2342,898,72010,353Apr 15, 2011, 11:50 AM
Cox JohnEVP Pharmaceutical Oper & TechApr 11, 2011 Option Exercise$47.926,900330,64817,253Apr 13, 2011, 10:14 AM
Cox JohnEVP Pharmaceutical Oper & TechApr 11, 2011 Sale$78.006,900538,20010,353Apr 13, 2011, 10:14 AM
Clancy Paul JExecutive VP and CFOMar 05, 2011 Option Exercise$71.1525,8881,841,93147,197Apr 08, 2011, 10:38 AM
Clancy Paul JExecutive VP and CFOMar 05, 2011 Option Exercise$58.9928,7501,695,96373,085Apr 08, 2011, 10:38 AM
Cox JohnEVP Pharmaceutical Oper & TechMar 31, 2011 Option Exercise$43.502,840123,54012,658Apr 01, 2011, 03:20 PM
Cox JohnEVP Pharmaceutical Oper & TechMar 31, 2011 Sale$73.002,840207,3209,818Apr 01, 2011, 03:20 PM
SCHNEIER CRAIG ERICEVP, HR, Public Affairs & CommMar 01, 2011 Option Exercise$49.656,250310,31323,962Mar 03, 2011, 03:17 PM
SCHNEIER CRAIG ERICEVP, HR, Public Affairs & CommMar 02, 2011 Sale$70.107,511526,55213,633Mar 03, 2011, 03:17 PM
SCHNEIER CRAIG ERICEVP, HR, Public Affairs & CommMar 01, 2011 Sale$68.626,250428,87517,712Mar 03, 2011, 03:17 PM
Cox JohnEVP Pharmaceutical Oper & TechMar 02, 2011 Sale$70.104,041283,25912,401Mar 03, 2011, 03:10 PM
Gagnon Robert E.Chief Acct Officer VP & ContrMar 02, 2011 Sale$70.021,40298,16410,788Mar 03, 2011, 03:08 PM
ALEXANDER SUSAN HEVP, General CounselFeb 24, 2011 Option Exercise$67.261,980133,17540,953Feb 28, 2011, 03:41 PM
Clancy Paul JExecutive VP and CFOFeb 24, 2011 Option Exercise$67.262,164145,55145,401Feb 28, 2011, 03:39 PM
Gagnon Robert E.Chief Acct Officer VP & ContrFeb 24, 2011 Option Exercise$67.2633522,53211,056Feb 28, 2011, 03:36 PM
SCHNEIER CRAIG ERICEVP, HR, Public Affairs & CommFeb 24, 2011 Option Exercise$67.262,156145,01318,707Feb 28, 2011, 03:34 PM
Cox JohnEVP Pharmaceutical Oper & TechFeb 24, 2011 Option Exercise$67.261,20280,84714,463Feb 28, 2011, 03:32 PM
Cox JohnEVP Pharmaceutical Oper & TechFeb 23, 2011 Option Exercise$66.7668045,39715,190Feb 25, 2011, 03:56 PM
Clancy Paul JExecutive VP and CFOFeb 23, 2011 Option Exercise$66.761,11974,70446,711Feb 25, 2011, 03:55 PM
Gagnon Robert E.Chief Acct Officer VP & ContrFeb 23, 2011 Option Exercise$66.7632021,36311,284Feb 25, 2011, 03:54 PM
Gagnon Robert E.Chief Acct Officer VP & ContrFeb 24, 2011 Option Exercise$49.651,05452,33112,277Feb 25, 2011, 03:54 PM
Gagnon Robert E.Chief Acct Officer VP & ContrFeb 24, 2011 Sale$66.991,05470,60611,223Feb 25, 2011, 03:54 PM
SCHNEIER CRAIG ERICEVP, HR, Public Affairs & CommFeb 23, 2011 Option Exercise$66.761,598106,68220,171Feb 25, 2011, 03:53 PM
SCHNEIER CRAIG ERICEVP, HR, Public Affairs & CommFeb 25, 2011 Option Exercise$49.319,725479,54029,593Feb 25, 2011, 03:53 PM
SCHNEIER CRAIG ERICEVP, HR, Public Affairs & CommFeb 25, 2011 Sale$68.209,725663,24519,868Feb 25, 2011, 03:53 PM
ALEXANDER SUSAN HEVP, General CounselFeb 23, 2011 Option Exercise$66.7699966,69342,128Feb 25, 2011, 03:51 PM
Gagnon Robert E.Chief Acct Officer VP & ContrFeb 17, 2011 Sale$67.1073249,11510,537Feb 18, 2011, 03:09 PM
SCHNEIER CRAIG ERICEVP, HR, Public Affairs & CommFeb 17, 2011 Sale$67.083,194214,24216,436Feb 18, 2011, 03:07 PM
Cox JohnEVP Pharmaceutical Oper & TechFeb 17, 2011 Sale$67.081,843123,62013,603Feb 18, 2011, 03:06 PM
SCHNEIER CRAIG ERICEVP, HR, Public Affairs & CommFeb 12, 2011 Option Exercise$65.831,48697,82319,630Feb 15, 2011, 02:31 PM
Gagnon Robert E.Chief Acct Officer VP & ContrFeb 12, 2011 Option Exercise$65.8334122,44811,269Feb 15, 2011, 02:29 PM
Cox JohnEVP Pharmaceutical Oper & TechFeb 12, 2011 Option Exercise$65.8391059,90515,446Feb 15, 2011, 02:27 PM
Clancy Paul JExecutive VP and CFOFeb 12, 2011 Option Exercise$65.831,686110,98944,097Feb 15, 2011, 02:26 PM
ALEXANDER SUSAN HEVP, General CounselFeb 12, 2011 Option Exercise$65.831,51599,73239,793Feb 15, 2011, 02:24 PM
Granata FrancescoEVP Global Commercial OperatioFeb 01, 2011 Option Exercise$65.491,38590,7043,162Feb 03, 2011, 05:14 PM
SCHNEIER CRAIG ERICEVP, HR, Public Affairs & CommJan 20, 2011 Option Exercise$49.656,250310,31327,366Jan 24, 2011, 02:59 PM
SCHNEIER CRAIG ERICEVP, HR, Public Affairs & CommJan 20, 2011 Sale$68.626,250428,87521,116Jan 24, 2011, 02:59 PM
Gagnon Robert E.Chief Acct Officer VP & ContrJan 04, 2011 Option Exercise$46.074,307198,41512,514Jan 05, 2011, 02:45 PM
Gagnon Robert E.Chief Acct Officer VP & ContrJan 04, 2011 Sale$66.575,103339,69010,814Jan 05, 2011, 02:45 PM
YOUNG WILLIAMDirectorDec 31, 2010 Option Exercise$67.0513,256888,81521,059Jan 04, 2011, 03:58 PM
YOUNG WILLIAMDirectorDec 31, 2010 Option Exercise$59.2515,000888,75034,315Jan 04, 2011, 03:58 PM
SCHENK LYNNDirectorDec 30, 2010 Option Exercise$59.2515,000888,75022,980Jan 03, 2011, 09:57 AM
SCHENK LYNNDirectorDec 30, 2010 Sale$66.8015,0001,001,9887,980Jan 03, 2011, 09:57 AM
SCHNEIER CRAIG ERICEVP, HR, Public Affairs & CommDec 17, 2010 Option Exercise$49.3119,450959,08040,566Dec 21, 2010, 03:32 PM
SCHNEIER CRAIG ERICEVP, HR, Public Affairs & CommDec 17, 2010 Sale$68.2019,4501,326,49021,116Dec 21, 2010, 03:32 PM
Gagnon Robert E.Chief Acct Officer VP & ContrDec 06, 2010 Sale$66.5379652,95711,610Dec 07, 2010, 05:14 PM
SCHNEIER CRAIG ERICEVP, HR, Public Affairs & CommDec 07, 2010 Option Exercise$44.2428,0931,242,83449,209Dec 07, 2010, 05:13 PM
SCHNEIER CRAIG ERICEVP, HR, Public Affairs & CommDec 03, 2010 Option Exercise$44.241,90784,36623,023Dec 07, 2010, 05:13 PM
SCHNEIER CRAIG ERICEVP, HR, Public Affairs & CommDec 07, 2010 Sale$67.2028,0931,887,85021,116Dec 07, 2010, 05:13 PM
SCHNEIER CRAIG ERICEVP, HR, Public Affairs & CommDec 03, 2010 Sale$67.201,907128,15021,116Dec 07, 2010, 05:13 PM
Gagnon Robert E.Chief Acct Officer VP & ContrDec 01, 2010 Option Exercise$65.3737124,25212,406Dec 03, 2010, 01:46 PM
Cox JohnEVP Pharmaceutical Oper & TechNov 09, 2010 Sale$62.8777348,59716,356Nov 10, 2010, 02:21 PM
Cox JohnEVP Pharmaceutical Oper & TechNov 09, 2010 Sale$62.8777348,59716,356Nov 10, 2010, 02:21 PM
Cox JohnEVP Pharmaceutical Oper & TechNov 01, 2010 Option Exercise$62.5536022,51817,894Nov 03, 2010, 01:50 PM
Cox JohnEVP Pharmaceutical Oper & TechNov 01, 2010 Option Exercise$62.5536022,51817,894Nov 03, 2010, 01:50 PM
Cox JohnEVP Pharmaceutical Oper & TechNov 02, 2010 Sale$63.0476548,22817,129Nov 03, 2010, 01:50 PM
Cox JohnEVP Pharmaceutical Oper & TechNov 02, 2010 Sale$63.0476548,22817,129Nov 03, 2010, 01:50 PM
PANGIA ROBERT WDirectorOct 28, 2010 Option Exercise$59.2515,000888,75029,080Oct 29, 2010, 02:27 PM
PANGIA ROBERT WDirectorOct 28, 2010 Sale$64.0015,000960,00014,080Oct 29, 2010, 02:27 PM
Cox JohnEVP Pharmaceutical Oper & TechOct 28, 2010 Option Exercise$33.976,900234,39325,154Oct 29, 2010, 02:25 PM
Cox JohnEVP Pharmaceutical Oper & TechOct 28, 2010 Option Exercise$33.976,900234,39325,154Oct 29, 2010, 02:25 PM
Cox JohnEVP Pharmaceutical Oper & TechOct 28, 2010 Sale$63.006,900434,70018,254Oct 29, 2010, 02:25 PM
Cox JohnEVP Pharmaceutical Oper & TechOct 28, 2010 Sale$63.006,900434,70018,254Oct 29, 2010, 02:25 PM
MacLean Michael FSVP, Chief Accounting OfficerOct 01, 2010 Option Exercise$56.5395353,87310,681Oct 04, 2010, 04:14 PM
Clancy Paul JExecutive VP and CFOSep 04, 2010 Option Exercise$56.241,11462,65145,783Sep 07, 2010, 04:05 PM
DORSA CAROLINEDirectorAug 13, 2010 Buy$56.411779,9858,243Aug 17, 2010, 04:35 PM
MacLean Michael FSVP, Chief Accounting OfficerAug 02, 2010 Sale$56.859,542542,45720,494Aug 03, 2010, 04:03 PM
MacLean Michael FSVP, Chief Accounting OfficerAug 02, 2010 Sale$56.859,542542,45720,494Aug 03, 2010, 04:03 PM
Clancy Paul JExecutive VP and CFOAug 01, 2010 Option Exercise$55.8883546,66046,897Aug 03, 2010, 04:01 PM
ALEXANDER SUSAN HEVP, General CounselAug 01, 2010 Option Exercise$55.8883546,66041,308Aug 03, 2010, 04:00 PM
DORSA CAROLINEDirectorJul 30, 2010 Buy$54.571839,9868,066Aug 03, 2010, 03:58 PM
Load More Insider Transactions
Buy Sale Option Exercise
OwnerRelationshipDateValue($)
Singhal PriyaHead of Development02/22/202457,962
ALEXANDER SUSAN HEVP Chief Legal Officer02/16/2024533,898
Gregory GingerEVP, Human Resources02/16/2024495,997
Izzar RachidHead of Global Product Strat.02/16/2024208,564
Kramer RobinChief Accounting Officer02/16/202486,756
MCDONNELL MICHAEL REVP, Chief Financial Officer02/16/2024753,197
Murphy NicoleHead of Pharm Ops and Tech02/16/2024133,639
Singhal PriyaHead of Development02/16/2024102,529
Singhal PriyaHead of Development02/16/202423,921
Rowinsky Eric KDirector02/15/2024101,256
Gregory GingerEVP, Human Resources02/09/2024152,781
Singhal PriyaHead of Development02/09/202490,127
Singhal PriyaHead of Development02/12/2024100,330
Murphy NicoleHead of Pharm Ops and Tech02/09/2024183,386
MCDONNELL MICHAEL REVP, Chief Financial Officer02/09/2024344,842
Kramer RobinChief Accounting Officer02/09/202459,040
Izzar RachidHead of Global Product Strat.02/09/2024107,236
ALEXANDER SUSAN HEVP Chief Legal Officer02/09/2024226,039
ALEXANDER SUSAN HEVP Chief Legal Officer02/08/2024157,397
Gregory GingerEVP, Human Resources02/08/2024119,669
Izzar RachidHead of Global Product Strat.02/08/2024149,226
Kramer RobinChief Accounting Officer02/08/202460,796
MCDONNELL MICHAEL REVP, Chief Financial Officer02/08/2024183,830
Murphy NicoleHead of Pharm Ops and Tech02/08/2024153,311
Singhal PriyaHead of Development02/01/2024139,033
Singhal PriyaHead of Development02/02/2024155,920
Singhal PriyaHead of Development12/08/202349,294
Singhal PriyaHead of Development12/11/202327,280
Kramer RobinChief Accounting Officer12/08/202340,679
MCDONNELL MICHAEL REVP, Chief Financial Officer09/01/2023722,428
Singhal PriyaHead of Development09/01/2023215,606
Singhal PriyaHead of Development09/05/2023116,124
Izzar RachidHead of Global Product Strat.06/30/202369,503
Kramer RobinChief Accounting Officer06/30/202334,752
Singhal PriyaHead of Development06/30/202343,582
Singhal PriyaHead of Development07/03/202322,912
Gregory GingerEVP, Human Resources04/28/2023804,300
Singhal PriyaHead of Development04/04/202325,217
Murphy NicoleHead of Pharm Ops and Tech03/31/202332,251
Singhal PriyaHead of Development03/28/2023153,394
Singhal PriyaHead of Development03/02/2023184,631
Singhal PriyaHead of Development02/17/202342,035
Murphy NicoleHead of Pharm Ops and Tech02/17/202364,863
MCDONNELL MICHAEL REVP, Chief Financial Officer02/17/2023364,678
Kramer RobinChief Accounting Officer02/17/202366,254
Izzar RachidHead of Global Product Strat.02/17/2023103,279
Gregory GingerEVP, Human Resources02/17/2023241,355
ALEXANDER SUSAN HEVP Chief Legal Off & Corp Sec02/17/2023258,615
ALEXANDER SUSAN HEVP Chief Legal Off & Corp Sec02/10/20231,203,033
Gregory GingerEVP, Human Resources02/10/2023946,508
Izzar RachidHead of Global Product Strat.02/10/2023379,061
Kramer RobinChief Accounting Officer02/10/2023168,917
MCDONNELL MICHAEL REVP, Chief Financial Officer02/10/2023316,361
Murphy NicoleHead of Pharm Ops and Tech02/10/2023397,098
Singhal PriyaHead of Development02/10/2023106,504
Gregory GingerEVP, Human Resources11/14/20221,683,617
Kramer RobinChief Accounting Officer12/08/202245,100
Izzar RachidHead of Alzheimer's Disease12/02/2022226,865
Murphy NicoleHead of Pharm Ops and Tech12/02/202211,657
ALEXANDER SUSAN HEVP Chief Legal Off & Corp Sec10/27/20221,552,832
MCDONNELL MICHAEL REVP, Chief Financial Officer09/01/2022485,090
Murphy NicoleHead of Pharm Ops and Tech08/01/202266,754
Kramer RobinChief Accounting Officer07/01/202215,587
Izzar RachidHead of Alzheimer's Disease07/01/202231,173
Murphy NicoleHead of Pharm Ops and Tech04/01/202217,695
Vounatsos MichelChief Executive Officer02/18/2022576,083
Murphy NicoleHead of Pharm Ops and Tech02/18/202223,077
MCDONNELL MICHAEL REVP, Chief Financial Officer02/18/2022204,965
Gregory GingerEVP, Human Resources02/18/2022129,231
ALEXANDER SUSAN HEVP Chief Legal Off & Corp Sec02/18/2022138,252
ALEXANDER SUSAN HEVP Chief Legal Off & Corp Sec02/12/2022441,197
Gregory GingerEVP, Human Resources02/12/2022268,667
Guindo ChirfiHead of Glob Prod Strat & Com02/12/2022502,570
Kramer RobinChief Accounting Officer12/03/202122,392
Kramer RobinChief Accounting Officer12/03/202175,909
Izzar RachidHead of Alzheimer's Disease12/02/202137,706
Izzar RachidHead of Alzheimer's Disease12/02/202185,009
MCDONNELL MICHAEL REVP, Chief Financial Officer09/01/2021873,336
MCDONNELL MICHAEL REVP, Chief Financial Officer09/01/20212,031,131
Kramer RobinChief Accounting Officer07/01/202125,820
Kramer RobinChief Accounting Officer07/01/202187,579
Sandrock AlfredHead of Research & Development06/07/20213,375,680
Guindo ChirfiHead of Glob Prod Strat & Com06/07/20211,358,280
Posner Brian SDirector06/04/202198,701
Vounatsos MichelChief Executive Officer02/12/20214,023,928
Sandrock AlfredEVP, Research & Development02/12/2021975,885
Kramer RobinSVP, Chief Accounting Officer02/12/202131,973
Gregory GingerEVP, Human Resources02/12/2021606,661
Galdes AlphonseEVP Pharmaceutical Oper & Tech02/12/2021198,791
ALEXANDER SUSAN HEVP Chief Legal Off & Corp Sec02/12/20211,083,205
Guindo ChirfiEVP Glob. Prod Strat and Comm02/12/2021261,348
Mantas Jesus BDirector02/09/2021239,766
Kramer RobinVP, Chief Accounting Officer12/03/20205,370
Guindo ChirfiEVP Glob. Prod Strat and Comm12/01/2020136,656
Vounatsos MichelChief Executive Officer11/30/2020748,045
Sandrock AlfredEVP, Research & Development11/04/2020525,000
Gregory GingerEVP, Human Resources07/31/202061,256
SHERWIN STEPHEN ADirector03/11/2020717,772
SHERWIN STEPHEN ADirector03/11/2020718,574
Vounatsos MichelChief Executive Officer02/15/2020715,950
Sandrock AlfredEVP, Research & Development02/15/2020179,154
Galdes AlphonseEVP Pharmaceutical Oper & Tech02/15/202043,290
ALEXANDER SUSAN HEVP Chief Legal Off & Corp Sec02/15/2020229,437
Kramer RobinVP, Chief Accounting Officer02/12/202015,261
Karp DanielEVP, Corporate Development02/12/202097,537
Guindo ChirfiEVP Glob. Prod Strat and Comm02/12/2020167,207
Gregory GingerEVP, Human Resources02/12/2020384,510
Galdes AlphonseEVP Pharmaceutical Oper & Tech02/12/2020116,448
CAPELLO JEFFREY DEVP & Chief Financial Officer02/12/2020203,701
ALEXANDER SUSAN HEVP Chief Legal Off & Corp Sec02/12/2020741,484
Vounatsos MichelChief Executive Officer02/12/20201,623,965
Sandrock AlfredEVP, Research & Development02/12/2020630,676
CAPELLO JEFFREY DEVP & Chief Financial Officer01/02/2020119,445
Kramer RobinVP, Chief Accounting Officer12/03/20197,268
Guindo ChirfiEVP Glob. Prod Strat and Comm12/01/2019117,226
Posner Brian SDirector12/02/2019308,429
Gregory GingerEVP, Human Resources08/01/201950,556
Karp DanielEVP, Corporate Development07/02/201913,709
Ehlers Michael DEVP, Research and Development06/01/2019210,518
Vounatsos MichelChief Executive Officer05/02/2019151,682
DENNER ALEXANDER JDirector05/02/20198,787,120
DENNER ALEXANDER JDirector05/01/20196,883,800
DENNER ALEXANDER JDirector04/30/201911,540,904
Vounatsos MichelChief Executive Officer05/01/20191,007,169
PANGIA ROBERT WDirector03/18/2019319,273
PANGIA ROBERT WDirector03/18/20192,008,755
McKenzie PaulEVP Pharmaceutical Oper & Tech03/01/2019219,838
ALEXANDER SUSAN HEVP Chief Legal Officer & Sec.02/22/20191,336,781
ALEXANDER SUSAN HEVP Chief Legal Officer & Sec.02/22/2019310,285
Sandrock AlfredEVP, Chief Medical Officer02/22/2019240,419
Vounatsos MichelChief Executive Officer02/15/2019778,916
Sandrock AlfredEVP, Chief Medical Officer02/15/2019195,062
McKenzie PaulEVP Pharmaceutical Oper & Tech02/15/2019214,035
Ehlers Michael DEVP, Research and Development02/15/2019249,320
ALEXANDER SUSAN HEVP Chief Legal Officer & Sec.02/15/2019249,320
Vounatsos MichelChief Executive Officer02/12/2019837,545
Sandrock AlfredEVP, Chief Medical Officer02/12/2019804,325
McKenzie PaulEVP Pharmaceutical Oper & Tech02/12/2019293,556
Gregory GingerEVP, Human Resources02/12/2019176,006
Ehlers Michael DEVP, Research and Development02/12/2019404,718
ALEXANDER SUSAN HEVP Chief Legal Officer & Sec.02/12/2019326,138
DENNER ALEXANDER JDirector01/30/20199,745,860
DENNER ALEXANDER JDirector02/01/20192,299,164
DENNER ALEXANDER JDirector01/31/20198,527,391
CAPELLO JEFFREY DEVP & Chief Financial Officer01/02/2019126,142
Guindo ChirfiEVP Glob. Mkt Acc & Cust Innov12/01/2018136,491
Ehlers Michael DEVP, Research and Development09/26/2018350,000
Gregory GingerEVP, Human Resources08/01/201856,082
Ehlers Michael DEVP, Research and Development06/01/2018319,669
Vounatsos MichelChief Executive Officer05/02/2018205,598
DENNER ALEXANDER JDirector04/25/201812,955,680
McKenzie PaulEVP Pharmaceutical Oper & Tech03/01/2018181,269
Sandrock AlfredEVP, Chief Medical Officer02/27/201875,325
Sandrock AlfredEVP, Chief Medical Officer02/23/201860,898
Sandrock AlfredEVP, Chief Medical Officer02/23/2018266,444
COVINO GREGORY FVP, Chief Accounting Officer02/23/20188,198
ALEXANDER SUSAN HEVP Chief Legal Corp Svc & Sec02/23/2018111,549
Sandrock AlfredEVP, Chief Medical Officer02/22/2018207,057
COVINO GREGORY FVP, Chief Accounting Officer02/22/201816,519
ALEXANDER SUSAN HEVP Chief Legal Corp Svc & Sec02/22/2018207,057
Sandrock AlfredEVP, Chief Medical Officer02/20/2018216,956
Sandrock AlfredEVP, Chief Medical Officer02/15/2018386,712
Vounatsos MichelChief Executive Officer02/15/2018561,936
Sandrock AlfredEVP, Chief Medical Officer02/15/2018178,430
Ehlers Michael DEVP, Research and Development02/15/2018152,384
ALEXANDER SUSAN HEVP Chief Legal Corp Svc & Sec02/15/2018152,684
COVINO GREGORY FVP, Chief Accounting Officer02/15/201816,765
McKenzie PaulEVP Pharmaceutical Oper & Tech02/15/2018132,326
Sandrock AlfredEVP, Chief Medical Officer02/12/2018416,685
PANGIA ROBERT WDirector01/09/2018337,265
PANGIA ROBERT WDirector01/09/20181,922,519
Vounatsos MichelChief Executive Officer12/29/2017250,029
COVINO GREGORY FVP, Chief Accounting Officer12/01/201750,138
DENNER ALEXANDER JDirector11/29/20173,198,400
DENNER ALEXANDER JDirector11/28/20176,322,400
DENNER ALEXANDER JDirector08/31/2017295,350
ALEXANDER SUSAN HEVP Chief Legal Corp Svc & Sec07/25/20171,442,510
ALEXANDER SUSAN HEVP Chief Legal Corp Svc & Sec07/19/20172,211,030
Posner Brian SDirector06/09/2017277,840
Ehlers Michael DEVP, Research and Development06/01/2017188,528
Vounatsos MichelChief Executive Officer05/02/2017153,036
Vounatsos MichelChief Executive Officer05/01/2017380,433
DENNER ALEXANDER JDirector04/27/201720,569,476
Clancy Paul JExecutive VP and CFO04/25/20172,868,680
Clancy Paul JExecutive VP and CFO03/13/20172,883,721
McKenzie PaulEVP Pharmaceutical Oper & Tech03/01/201746,042
Sandrock AlfredEVP CMO Neuro & Neurodegenerat03/01/2017282,238
Clancy Paul JExecutive VP and CFO02/28/2017853,135
Sandrock AlfredEVP CMO Neuro & Neurodegenerat02/28/2017829,217
ALEXANDER SUSAN HEVP, Chief Legal Officer02/28/2017670,996
COVINO GREGORY FVP, Chief Accounting Officer02/28/201725,386
Karaboutis AdrianaEVP, Tech, Bus. Sol & Corp Aff02/28/2017211,542
DiPietro KennethEVP Human Resources02/28/2017684,399
PANGIA ROBERT WDirector01/09/2017284,599
PANGIA ROBERT WDirector01/09/20171,609,876
Karaboutis AdrianaEVP, Tech, Bus. Sol & Corp Aff12/01/201650,578
Karaboutis AdrianaEVP, Tech, Bus. Sol & Corp Aff12/01/201614,233
COVINO GREGORY FVP, Chief Accounting Officer12/01/201615,676
Karaboutis AdrianaEVP, Tech, Bus. Sol & Corp Aff10/04/201681,728
Karaboutis AdrianaEVP, Tech, Bus. Sol & Corp Aff10/01/2016591,001
Karaboutis AdrianaEVP, Tech, Bus. Sol & Corp Aff10/03/2016118,940
DORSA CAROLINEDirector09/22/20161,478,855
DORSA CAROLINEDirector09/22/20168,656,980
SCANGOS GEORGE AChief Executive Officer07/21/201643,960
Koppel AdamEVP, Strategy and Bus. Dev.06/06/2016160,950
Koppel AdamEVP, Strategy and Bus. Dev.06/02/2016154,716
SCANGOS GEORGE AChief Executive Officer06/03/2016244,180
SCANGOS GEORGE AChief Executive Officer05/31/2016976,720
SCANGOS GEORGE AChief Executive Officer06/01/2016140,241
SCANGOS GEORGE AChief Executive Officer05/25/201643,960
SCANGOS GEORGE AChief Executive Officer05/02/2016133,798
COVINO GREGORY FVP, Chief Accounting Officer05/01/201631,074
Koppel AdamEVP, Strategy and Bus. Dev.04/06/201628,050
SCANGOS GEORGE AChief Executive Officer04/06/201643,960
Artavanis-Tsakonas SpyridonEVP, Chief Scientific Officer04/02/2016119,588
SCANGOS GEORGE AChief Executive Officer04/01/2016126,050
SCANGOS GEORGE AChief Executive Officer03/01/2016127,287
Sandrock AlfredEVP CMO Neuro & Neurodegenerat02/25/201647,928
Karaboutis AdrianaEVP, Tech, Bus. Sol & Corp Aff02/25/201622,000
Clancy Paul JExecutive VP and CFO02/23/201670,704
COVINO GREGORY FVP, Chief Accounting Officer02/23/20165,698
Artavanis-Tsakonas SpyridonSVP, Chief Scientific Officer02/23/201612,432
ALEXANDER SUSAN HEVP, Chief Legal Officer02/23/201677,697
Cox JohnEVP Pharmaceutical Oper & Tech02/23/201698,934
Koppel AdamEVP, Strategy and Bus. Dev.02/23/201625,381
DiPietro KennethEVP Human Resources02/23/201677,697
Holtzman Steven HEVP Corporate Development02/23/201670,704
Karaboutis AdrianaEVP, Tech, Bus. Sol & Corp Aff02/23/201641,956
Sandrock AlfredEVP CMO Neuro & Neurodegenerat02/23/201642,474
SCANGOS GEORGE AChief Executive Officer02/23/2016361,291
SCANGOS GEORGE AChief Executive Officer02/17/2016124,750
Sandrock AlfredEVP CMO Neuro & Neurodegenerat02/17/2016184,948
SCANGOS GEORGE AChief Executive Officer02/12/20162,920,904
Cox JohnEVP Pharmaceutical Oper & Tech02/12/2016383,685
DiPietro KennethEVP Human Resources02/12/2016338,444
COVINO GREGORY FVP, Chief Accounting Officer02/12/20166,428
Sandrock AlfredEVP CMO Neuro & Neurodegenerat02/12/2016451,671
Holtzman Steven HEVP Corporate Development02/12/2016324,847
ALEXANDER SUSAN HEVP, Chief Legal Officer02/12/2016328,308
Artavanis-Tsakonas SpyridonSVP, Chief Scientific Officer02/12/201687,021
Clancy Paul JExecutive VP and CFO02/12/2016420,027
SCANGOS GEORGE AChief Executive Officer02/09/20161,326,197
Sandrock AlfredEVP CMO Neuro & Neurodegenerat02/08/2016106,828
Sandrock AlfredEVP CMO Neuro & Neurodegenerat02/09/2016210,052
ALEXANDER SUSAN HEVP, Chief Legal Officer02/08/2016206,133
Clancy Paul JExecutive VP and CFO02/08/2016262,556
Cox JohnEVP Pharmaceutical Oper & Tech02/08/2016332,019
Holtzman Steven HEVP Corporate Development02/08/2016223,185
DiPietro KennethEVP Human Resources02/01/2016222,041
DiPietro KennethEVP Human Resources02/01/2016674,328
Sandrock AlfredEVP CMO Neuro & Neurodegenerat12/03/2015108,248
Sandrock AlfredEVP CMO Neuro & Neurodegenerat12/04/2015122,157
Karaboutis AdrianaEVP, Tech. and Bus. Solutions12/01/201549,597
Karaboutis AdrianaEVP, Tech. and Bus. Solutions12/02/201513,879
DENNER ALEXANDER JDirector10/23/201527,676,999
DENNER ALEXANDER JDirector10/22/201558,337,997
Karaboutis AdrianaEVP, Tech. and Bus. Solutions10/05/201578,395
Karaboutis AdrianaEVP, Tech. and Bus. Solutions10/01/2015478,642
Karaboutis AdrianaEVP, Tech. and Bus. Solutions10/02/2015118,169
PAPADOPOULOS STELIOSDirector07/27/20151,524,895
PAPADOPOULOS STELIOSDirector07/27/20151,523,880
Posner Brian SDirector06/22/2015195,050
WILLIAMS DOUGLAS EEVP Research & Development06/19/20151,574,810
Posner Brian SDirector06/15/2015154,656
Koppel AdamSVP, Chief Strategy Officer06/02/2015330,252
SCANGOS GEORGE AChief Executive Officer06/01/2015543,261
COVINO GREGORY FVP, Chief Accounting Officer05/01/201543,643
COVINO GREGORY FVP, Chief Accounting Officer05/01/2015134,018
SCANGOS GEORGE AChief Executive Officer05/01/2015514,182
Artavanis-Tsakonas SpyridonSVP, Chief Scientific Officer04/02/2015189,722
SCANGOS GEORGE AChief Executive Officer04/01/2015576,398
Sandrock AlfredGrp SVP, Chief Medical Officer03/27/2015184,952
Cox JohnEVP Pharmaceutical Oper & Tech03/25/2015333,571
Cox JohnEVP Pharmaceutical Oper & Tech03/25/20155,393,211
Rowinsky Eric KDirector03/20/2015697,920
Rowinsky Eric KDirector03/20/20155,541,825
Rowinsky Eric KDirector03/19/2015139,560
Rowinsky Eric KDirector03/19/20151,017,508
Rowinsky Eric KDirector03/17/2015279,180
Rowinsky Eric KDirector03/17/20151,985,589
DiPietro KennethEVP Human Resources03/16/2015333,614
SCANGOS GEORGE AChief Executive Officer03/13/2015221,613
SHERWIN STEPHEN ADirector03/10/2015358,920
SHERWIN STEPHEN ADirector03/10/20152,458,020
Rowinsky Eric KDirector03/09/2015279,120
Rowinsky Eric KDirector03/09/20151,946,795
PANGIA ROBERT WDirector03/10/2015172,954
PANGIA ROBERT WDirector03/10/20151,498,578
Sandrock AlfredGrp SVP, Chief Medical Officer03/01/20151,157,501
Sandrock AlfredGrp SVP, Chief Medical Officer03/02/20151,299,715
SCANGOS GEORGE AChief Executive Officer03/02/2015338,803
COVINO GREGORY FVP, Chief Accounting Officer02/12/20153,137
SCANGOS GEORGE AChief Executive Officer02/19/2015215,358
SCANGOS GEORGE AChief Executive Officer02/17/2015321,016
Holtzman Steven HEVP Corporate Development02/17/2015828,026
DiPietro KennethEVP Human Resources02/17/2015462,263
Sandrock AlfredGrp SVP, Chief Medical Officer02/17/2015162,648
SCANGOS GEORGE AChief Executive Officer02/12/20154,754,334
COVINO GREGORY FVP, Chief Accounting Officer02/12/20157,842
Holtzman Steven HEVP Corporate Development02/12/2015671,292
Artavanis-Tsakonas SpyridonSVP, Chief Scientific Officer02/12/2015154,491
Sandrock AlfredGrp SVP, Chief Medical Officer02/12/2015296,827
Clancy Paul JExecutive VP and CFO02/12/2015794,415
Cox JohnEVP Pharmaceutical Oper & Tech02/12/2015690,506
WILLIAMS DOUGLAS EEVP Research & Development02/12/2015960,669
ALEXANDER SUSAN HEVP, Chief Legal Officer02/12/2015696,387
DiPietro KennethEVP Human Resources02/12/2015695,211
Kingsley Stuart AEVP, Global Comm. Operations02/12/2015665,411
Sandrock AlfredGrp SVP, Chief Medical Officer02/10/2015455,039
SCANGOS GEORGE AChief Executive Officer02/10/20153,505,198
SCANGOS GEORGE AChief Executive Officer02/09/20151,960,587
WILLIAMS DOUGLAS EEVP Research & Development02/08/2015656,868
ALEXANDER SUSAN HEVP, Chief Legal Officer02/09/2015731,053
ALEXANDER SUSAN HEVP, Chief Legal Officer02/08/2015328,836
Sandrock AlfredGrp SVP, Chief Medical Officer02/09/2015270,275
Sandrock AlfredGrp SVP, Chief Medical Officer02/08/2015169,242
Sandrock AlfredGrp SVP, Chief Medical Officer02/09/2015340,731
Holtzman Steven HEVP Corporate Development02/08/2015512,550
Kingsley Stuart AEVP, Global Comm. Operations02/09/2015341,317
Kingsley Stuart AEVP, Global Comm. Operations02/08/2015354,966
Cox JohnEVP Pharmaceutical Oper & Tech02/09/2015877,105
Cox JohnEVP Pharmaceutical Oper & Tech02/08/2015617,874
Clancy Paul JExecutive VP and CFO02/08/2015459,486
Clancy Paul JExecutive VP and CFO02/09/2015877,105
DiPietro KennethEVP Human Resources02/02/2015644,234
DiPietro KennethEVP Human Resources02/01/2015314,052
WILLIAMS DOUGLAS EEVP Research & Development02/01/2015801,280
Holtzman Steven HEVP Corporate Development02/01/2015801,670
Artavanis-Tsakonas SpyridonSVP, Chief Scientific Officer12/15/2014686,417
Sandrock AlfredGrp SVP, Chief Medical Officer12/03/2014136,505
Sandrock AlfredGrp SVP, Chief Medical Officer12/04/2014152,187
Holtzman Steven HEVP Corporate Development12/02/2014587,052
Holtzman Steven HEVP Corporate Development11/11/2014577,500
SCANGOS GEORGE AChief Executive Officer11/03/2014361,840
SCANGOS GEORGE AChief Executive Officer10/01/2014373,003
Holtzman Steven HEVP Corporate Development10/01/2014579,198
SCANGOS GEORGE AChief Executive Officer09/02/2014389,690
SCANGOS GEORGE AChief Executive Officer08/01/2014375,545
SCANGOS GEORGE AChief Executive Officer07/16/20143,847,149
SCANGOS GEORGE AChief Executive Officer07/15/20143,139,344
Posner Brian SDirector06/20/2014190,575
Posner Brian SDirector06/13/2014217,350
SCANGOS GEORGE AChief Executive Officer06/02/2014154,362
Holtzman Steven HEVP Corporate Development05/19/2014353,052
SCANGOS GEORGE AChief Executive Officer05/01/2014606,241
COVINO GREGORY FVP, Chief Accounting Officer05/01/201432,403
COVINO GREGORY FVP, Chief Accounting Officer05/01/201499,502
Holtzman Steven HEVP Corporate Development04/17/2014355,311
Artavanis-Tsakonas SpyridonSVP, Chief Scientific Officer04/02/2014134,100
PANGIA ROBERT WDirector04/01/2014297,187
PANGIA ROBERT WDirector04/01/20141,927,625
SCANGOS GEORGE AChief Executive Officer04/01/2014654,776
Posner Brian SDirector03/31/2014890,275
DORSA CAROLINEDirector03/20/2014536,400
DORSA CAROLINEDirector03/20/20143,488,812
WILLIAMS DOUGLAS EEVP Research & Development03/19/20141,234,776
Holtzman Steven HEVP Corporate Development03/17/2014408,827
SCANGOS GEORGE AChief Executive Officer03/10/20148,719,378
LEAMING NANCYDirector03/10/2014655,300
Kingsley Stuart AEVP, Global Comm. Operations03/11/20142,838,766
Sandrock AlfredGrp SVP, Chief Medical Officer03/04/20141,086,321
Sandrock AlfredGrp SVP, Chief Medical Officer03/03/2014963,784
SCANGOS GEORGE AChief Executive Officer03/03/2014987,894
Sandrock AlfredGrp SVP, Chief Medical Officer02/26/2014358,594
Sandrock AlfredGrp SVP, Chief Medical Officer02/23/2014326,283
Cox JohnEVP Pharmaceutical Oper & Tech02/23/2014426,251
Clancy Paul JExecutive VP and CFO02/23/2014700,468
ALEXANDER SUSAN HEVP, Chief Legal Officer02/23/2014625,839
Holtzman Steven HEVP Corporate Development02/18/2014400,694
WILLIAMS DOUGLAS EEVP Research & Development02/12/2014544,322
Clancy Paul JExecutive VP and CFO02/12/2014427,705
Artavanis-Tsakonas SpyridonSVP, Chief Scientific Officer02/12/201477,207
ALEXANDER SUSAN HEVP, Chief Legal Officer02/12/2014326,270
Sandrock AlfredGrp SVP, Chief Medical Officer02/12/2014118,556
Sandrock AlfredGrp SVP, Chief Medical Officer02/13/2014134,478
Holtzman Steven HEVP Corporate Development02/12/2014326,270
COVINO GREGORY FVP, Chief Accounting Officer02/12/20142,584
SCANGOS GEORGE AChief Executive Officer02/12/20141,399,732
SCANGOS GEORGE AChief Executive Officer02/13/2014153,970
DiPietro KennethEVP Human Resources02/12/2014308,826
DiPietro KennethEVP Human Resources02/13/2014408,685
Cox JohnEVP Pharmaceutical Oper & Tech02/12/2014342,099
Sandrock AlfredGrp SVP, Chief Medical Officer02/11/2014655,336
SCANGOS GEORGE AChief Executive Officer02/11/2014771,945
SCANGOS GEORGE AChief Executive Officer02/10/20142,801,995
SCANGOS GEORGE AChief Executive Officer02/09/20141,530,369
Kingsley Stuart AEVP, Global Comm. Operations02/09/2014271,680
Kingsley Stuart AEVP, Global Comm. Operations02/08/2014392,216
Clancy Paul JExecutive VP and CFO02/08/2014330,370
Clancy Paul JExecutive VP and CFO02/09/2014697,974
WILLIAMS DOUGLAS EEVP Research & Development02/08/2014516,223
Holtzman Steven HEVP Corporate Development02/08/2014402,629
Sandrock AlfredGrp SVP, Chief Medical Officer02/09/2014187,431
Sandrock AlfredGrp SVP, Chief Medical Officer02/08/2014133,158
ALEXANDER SUSAN HEVP, Chief Legal Officer02/09/2014550,933
ALEXANDER SUSAN HEVP, Chief Legal Officer02/08/2014258,427
Cox JohnEVP Pharmaceutical Oper & Tech02/09/2014697,974
Cox JohnEVP Pharmaceutical Oper & Tech02/08/2014454,693
DiPietro KennethEVP Human Resources02/04/2014494,862
DiPietro KennethEVP Human Resources02/01/2014252,613
WILLIAMS DOUGLAS EEVP Research & Development02/01/2014615,588
Kingsley Stuart AEVP, Global Comm. Operations02/01/2014531,801
Holtzman Steven HEVP Corporate Development02/01/2014616,213
Rowinsky Eric KDirector01/21/2014626,382
SCHENK LYNNDirector01/15/2014297,480
YOUNG WILLIAMDirector01/08/20144,276,590
PANGIA ROBERT WDirector01/06/2014297,187
PANGIA ROBERT WDirector01/06/20141,737,687
SHERWIN STEPHEN ADirector01/02/2014329,010
SHERWIN STEPHEN ADirector01/02/20141,536,059
Sandrock AlfredGrp SVP, Chief Medical Officer12/03/2013113,377
Sandrock AlfredGrp SVP, Chief Medical Officer12/04/2013125,510
SCHENK LYNNDirector12/02/2013291,710
Pawlicki RaymondSVP, Chief Information Officer11/22/2013199,800
Pawlicki RaymondSVP, Chief Information Officer11/22/20131,152,000
SCHENK LYNNDirector11/01/2013245,000
SCANGOS GEORGE AChief Executive Officer11/01/2013549,831
Sandrock AlfredGrp SVP, Chief Medical Officer10/22/2013910,217
Sandrock AlfredGrp SVP, Chief Medical Officer10/22/20133,759,123
SCHENK LYNNDirector10/01/2013242,850
SCANGOS GEORGE AChief Executive Officer10/01/2013543,741
DiPietro KennethEVP Human Resources09/30/2013348,480
Clancy Paul JExecutive VP and CFO09/18/20131,329,875
Clancy Paul JExecutive VP and CFO09/18/20136,562,325
Clancy Paul JExecutive VP and CFO09/16/20135,556,895
Clancy Paul JExecutive VP and CFO09/16/201323,596,311
Holtzman Steven HEVP Corporate Development09/17/2013836,669
Sandrock AlfredGrp SVP, Chief Medical Officer09/16/2013487,563
Sandrock AlfredGrp SVP, Chief Medical Officer09/16/20132,357,821
Pawlicki RaymondSVP, Chief Information Officer09/16/2013198,360
Pawlicki RaymondSVP, Chief Information Officer09/16/2013952,120
SCHENK LYNNDirector09/11/2013211,726
SCANGOS GEORGE AChief Executive Officer09/03/2013480,042
WILLIAMS DOUGLAS EEVP Research & Development08/26/2013923,168
SCANGOS GEORGE AChief Executive Officer08/01/2013489,938
SCANGOS GEORGE AChief Executive Officer07/16/2013501,402
SCANGOS GEORGE AChief Executive Officer07/15/20134,489,068
DENNER ALEXANDER JDirector06/14/2013614,800
PAPADOPOULOS STELIOSDirector06/11/2013443,632
Posner Brian SDirector06/11/2013443,632
SCHENK LYNNDirector06/10/2013451,633
SCANGOS GEORGE AChief Executive Officer06/03/2013374,188
SHERWIN STEPHEN ADirector06/03/2013767,191
SHERWIN STEPHEN ADirector06/03/20132,991,605
Mulligan RichardDirector05/29/2013160,290
DENNER ALEXANDER JDirector05/29/2013160,290
Mulligan RichardDirector05/28/20132,029,004
Mulligan RichardDirector05/28/20139,140,100
DENNER ALEXANDER JDirector05/28/20132,029,004
DENNER ALEXANDER JDirector05/28/20139,135,697
PANGIA ROBERT WDirector05/28/20131,399,657
Pawlicki RaymondSVP, Chief Information Officer05/03/2013189,524
Cox JohnEVP Pharmaceutical Oper & Tech05/03/2013189,524
COVINO GREGORY FVP, Chief Accounting Officer05/01/201324,434
SCANGOS GEORGE AChief Executive Officer05/01/2013344,193
Clancy Paul JExecutive VP and CFO04/30/20133,255,090
Clancy Paul JExecutive VP and CFO04/29/20132,004,414
SCANGOS GEORGE AChief Executive Officer04/01/2013309,469
SCANGOS GEORGE AChief Executive Officer04/01/2013309,469
Mulligan RichardDirector03/22/2013512,952
SHERWIN STEPHEN ADirector03/22/2013265,320
Posner Brian SDirector03/18/2013786,645
Mulligan RichardDirector03/13/20131,399,530
PAPADOPOULOS STELIOSDirector03/11/20132,727,463
PAPADOPOULOS STELIOSDirector03/11/20138,040,003
Pawlicki RaymondSVP, Chief Information Officer03/01/2013106,281
SCANGOS GEORGE AChief Executive Officer03/01/2013264,149
Cox JohnEVP Pharmaceutical Oper & Tech02/23/2013201,719
ALEXANDER SUSAN HEVP, Chief Legal Officer02/23/2013296,413
Pawlicki RaymondSVP, Chief Information Officer02/23/2013118,697
Clancy Paul JExecutive VP and CFO02/23/2013332,252
SCANGOS GEORGE AChief Executive Officer02/13/2013261,097
Kingsley Stuart AEVP, Global Comm. Operations02/09/2013141,583
Kingsley Stuart AEVP, Global Comm. Operations02/08/2013136,650
Clancy Paul JExecutive VP and CFO02/09/2013284,646
Clancy Paul JExecutive VP and CFO02/08/2013147,832
Holtzman Steven HEVP Corporate Development02/08/2013154,574
Pawlicki RaymondSVP, Chief Information Officer02/09/2013146,845
Pawlicki RaymondSVP, Chief Information Officer02/08/201386,002
ALEXANDER SUSAN HEVP, General Counsel02/09/2013209,661
ALEXANDER SUSAN HEVP, General Counsel02/08/2013115,437
Cox JohnEVP Pharmaceutical Oper & Tech02/09/2013301,912
Cox JohnEVP Pharmaceutical Oper & Tech02/08/2013186,311
WILLIAMS DOUGLAS EEVP Research & Development02/08/2013205,879
SCANGOS GEORGE AChief Executive Officer02/10/20131,461,872
SCANGOS GEORGE AChief Executive Officer02/09/2013612,210
PANGIA ROBERT WDirector02/06/2013165,725
PANGIA ROBERT WDirector02/06/2013413,875
Pawlicki RaymondSVP, Chief Information Officer02/06/2013496,500
Pawlicki RaymondSVP, Chief Information Officer02/06/20131,655,500
WILLIAMS DOUGLAS EEVP Research & Development02/01/2013264,107
Holtzman Steven HEVP Corporate Development02/01/2013263,949
DiPietro KennethEVP Human Resources02/01/2013111,840
Kingsley Stuart AEVP, Global Comm. Operations02/01/2013234,534
DENNER ALEXANDER JDirector12/27/2012592,086
DENNER ALEXANDER JDirector12/26/2012593,914
SCANGOS GEORGE AChief Executive Officer11/01/2012344,640
SCANGOS GEORGE AChief Executive Officer10/01/2012545,031
PANGIA ROBERT WDirector09/17/2012331,450
PANGIA ROBERT WDirector09/17/2012775,000
PANGIA ROBERT WDirector09/06/2012331,450
PANGIA ROBERT WDirector09/06/2012750,000
SHERWIN STEPHEN ADirector09/04/2012291,800
SCANGOS GEORGE AChief Executive Officer09/04/2012533,119
ALEXANDER SUSAN HEVP, General Counsel08/02/2012166,583
SCANGOS GEORGE AChief Executive Officer08/01/2012534,727
ALEXANDER SUSAN HEVP, General Counsel07/27/20123,312,157
ALEXANDER SUSAN HEVP, General Counsel07/27/20128,710,500
SCANGOS GEORGE AChief Executive Officer07/17/2012361,011
SCANGOS GEORGE AChief Executive Officer07/16/20122,556,560
SCANGOS GEORGE AChief Executive Officer07/02/2012169,761
Pawlicki RaymondSVP, Chief Information Officer06/19/2012495,900
Pawlicki RaymondSVP, Chief Information Officer06/19/20121,430,000
ALEXANDER SUSAN HEVP, General Counsel06/15/20122,383,838
ALEXANDER SUSAN HEVP, General Counsel06/15/20126,972,000
PANGIA ROBERT WDirector06/15/2012184,700
PANGIA ROBERT WDirector06/15/2012700,000
Posner Brian SDirector06/07/2012178,450
Posner Brian SDirector06/07/2012337,500
PANGIA ROBERT WDirector06/04/2012184,700
PANGIA ROBERT WDirector06/04/2012650,000
SHERWIN STEPHEN ADirector06/04/2012316,125
Posner Brian SDirector06/04/2012171,312
Posner Brian SDirector06/04/2012303,480
Pawlicki RaymondSVP, Chief Information Officer06/04/2012135,049
SCANGOS GEORGE AChief Executive Officer06/01/2012152,169
Cox JohnEVP Pharmaceutical Oper & Tech05/03/2012102,709
Pawlicki RaymondSVP, Chief Information Officer05/03/2012102,709
SCHENK LYNNDirector05/02/2012319,244
SCHENK LYNNDirector05/02/2012806,625
SCHENK LYNNDirector05/02/20121,144,800
ALEXANDER SUSAN HEVP, General Counsel05/02/2012894,600
ALEXANDER SUSAN HEVP, General Counsel05/02/20122,700,000
ALEXANDER SUSAN HEVP, General Counsel04/25/2012749,854
ALEXANDER SUSAN HEVP, General Counsel04/25/20122,179,320
ALEXANDER SUSAN HEVP, General Counsel04/04/2012144,746
ALEXANDER SUSAN HEVP, General Counsel04/04/2012420,680
PANGIA ROBERT WDirector03/08/2012264,050
PANGIA ROBERT WDirector03/08/2012900,000
Gagnon Robert E.Vice President, Finance02/29/201282,821
Gagnon Robert E.Vice President, Finance02/28/201296,050
ALEXANDER SUSAN HEVP, General Counsel02/27/2012491,155
ALEXANDER SUSAN HEVP, General Counsel02/23/2012164,897
ALEXANDER SUSAN HEVP, General Counsel02/24/2012302,730
ALEXANDER SUSAN HEVP, General Counsel02/24/2012247,812
Cox JohnEVP Pharmaceutical Oper & Tech02/24/2012183,663
Cox JohnEVP Pharmaceutical Oper & Tech02/23/2012126,619
Gagnon Robert E.Vice President, Finance02/23/201245,280
Gagnon Robert E.Vice President, Finance02/24/201238,874
Gagnon Robert E.Vice President, Finance02/24/201252,331
Gagnon Robert E.Vice President, Finance02/24/2012121,769
Clancy Paul JExecutive VP and CFO02/24/2012324,263
Clancy Paul JExecutive VP and CFO02/23/2012208,426
SCANGOS GEORGE AChief Executive Officer07/15/2011914,264
Kingsley Stuart AEVP, Global Comm. Operations02/14/2012147,907
Gagnon Robert E.Vice President, Finance02/14/201266,422
ALEXANDER SUSAN HEVP, General Counsel02/13/2012335,384
Kingsley Stuart AEVP, Global Comm. Operations02/09/201268,195
Cox JohnEVP Pharmaceutical Oper & Tech02/09/2012177,141
Gagnon Robert E.Vice President, Finance02/09/201235,452
ALEXANDER SUSAN HEVP, General Counsel02/09/2012148,049
SCANGOS GEORGE AChief Executive Officer02/10/2012827,807
Clancy Paul JExecutive VP and CFO02/09/2012230,495
Kingsley Stuart AEVP, Global Comm. Operations02/06/2012376,403
Clancy Paul JExecutive VP and CFO02/01/20121,133,088
Clancy Paul JExecutive VP and CFO02/01/20122,568,000
WILLIAMS DOUGLAS EEVP Research & Development02/01/2012200,807
Holtzman Steven HEVP Corp Devel and Strategy02/01/2012201,049
Granata FrancescoEVP Global Commercial Operatio02/01/2012202,383
Kingsley Stuart AEVP, Global Comm. Operations02/01/2012179,101
LEAMING NANCYDirector02/01/2012337,269
LEAMING NANCYDirector02/01/2012684,000
LEAMING NANCYDirector01/20/2012167,910
LEAMING NANCYDirector01/20/2012354,000
LEAMING NANCYDirector01/06/2012167,910
LEAMING NANCYDirector01/06/2012348,000
Rowinsky Eric KDirector01/06/2012777,181
Rowinsky Eric KDirector01/06/20121,507,072
LEAMING NANCYDirector01/03/2012223,880
LEAMING NANCYDirector01/03/2012456,000
Clancy Paul JExecutive VP and CFO01/03/20122,274,398
SHERWIN STEPHEN ADirector12/19/2011277,200
Gagnon Robert E.Chief Acct Officer VP & Contr12/06/201189,286
Gagnon Robert E.Chief Acct Officer VP & Contr12/01/201143,214
Gagnon Robert E.Chief Acct Officer VP & Contr11/09/201189,184
Gagnon Robert E.Chief Acct Officer VP & Contr11/02/201142,083
Cox JohnEVP Pharmaceutical Oper & Tech11/01/2011158,492
Cox JohnEVP Pharmaceutical Oper & Tech11/01/2011248,755
Gagnon Robert E.Chief Acct Officer VP & Contr10/05/201124,610
Gagnon Robert E.Chief Acct Officer VP & Contr10/01/201110,992
Gagnon Robert E.Chief Acct Officer VP & Contr10/03/201138,581
Gagnon Robert E.Chief Acct Officer VP & Contr10/03/201172,004
YOUNG WILLIAMDirector09/27/20111,708,441
YOUNG WILLIAMDirector09/27/20113,196,655
LEAMING NANCYDirector09/16/2011308,500
YOUNG WILLIAMDirector09/01/20111,633,775
YOUNG WILLIAMDirector09/01/20113,325,000
Posner Brian SDirector08/29/20111,070,700
Posner Brian SDirector08/29/20111,387,894
YOUNG WILLIAMDirector08/29/2011681,500
YOUNG WILLIAMDirector08/29/2011925,784
ALEXANDER SUSAN HEVP, General Counsel08/01/201185,922
ALEXANDER SUSAN HEVP, General Counsel08/02/2011118,877
Clancy Paul JExecutive VP and CFO08/01/201185,922
SCANGOS GEORGE AChief Executive Officer07/20/20111,315,035
SCANGOS GEORGE AChief Executive Officer07/15/2011926,744
SCANGOS GEORGE AChief Executive Officer07/14/2011914,264
Granata FrancescoEVP Global Commercial Operatio07/01/2011311,918
LEAMING NANCYDirector06/14/2011213,022
Posner Brian SDirector05/25/20111,746,844
Posner Brian SDirector05/25/20112,444,027
LEAMING NANCYDirector05/26/20111,841,628
LEAMING NANCYDirector05/26/20113,087,085
PANGIA ROBERT WDirector05/26/2011853,200
PANGIA ROBERT WDirector05/26/20111,396,647
Gagnon Robert E.Chief Acct Officer VP & Contr05/06/201192,960
Gagnon Robert E.Chief Acct Officer VP & Contr05/03/201144,095
Gagnon Robert E.Chief Acct Officer VP & Contr05/04/201120,646
Cox JohnEVP Pharmaceutical Oper & Tech05/03/201174,962
Gagnon Robert E.Chief Acct Officer VP & Contr05/01/20119,863
ALEXANDER SUSAN HEVP, General Counsel05/02/20112,040,497
Clancy Paul JExecutive VP and CFO04/28/2011608,119
Clancy Paul JExecutive VP and CFO04/28/20111,950,088
Cox JohnEVP Pharmaceutical Oper & Tech04/21/2011316,985
Cox JohnEVP Pharmaceutical Oper & Tech04/21/2011435,000
SCHENK LYNNDirector04/20/20112,304,947
SCHENK LYNNDirector04/20/20113,176,461
Cox JohnEVP Pharmaceutical Oper & Tech04/13/20112,055,646
Cox JohnEVP Pharmaceutical Oper & Tech04/13/20112,898,720
Cox JohnEVP Pharmaceutical Oper & Tech04/11/2011330,648
Cox JohnEVP Pharmaceutical Oper & Tech04/11/2011538,200
Clancy Paul JExecutive VP and CFO03/05/20111,841,931
Clancy Paul JExecutive VP and CFO03/05/20111,695,963
Cox JohnEVP Pharmaceutical Oper & Tech03/31/2011123,540
Cox JohnEVP Pharmaceutical Oper & Tech03/31/2011207,320
SCHNEIER CRAIG ERICEVP, HR, Public Affairs & Comm03/01/2011310,313
SCHNEIER CRAIG ERICEVP, HR, Public Affairs & Comm03/02/2011526,552
SCHNEIER CRAIG ERICEVP, HR, Public Affairs & Comm03/01/2011428,875
Cox JohnEVP Pharmaceutical Oper & Tech03/02/2011283,259
Gagnon Robert E.Chief Acct Officer VP & Contr03/02/201198,164
ALEXANDER SUSAN HEVP, General Counsel02/24/2011133,175
Clancy Paul JExecutive VP and CFO02/24/2011145,551
Gagnon Robert E.Chief Acct Officer VP & Contr02/24/201122,532
SCHNEIER CRAIG ERICEVP, HR, Public Affairs & Comm02/24/2011145,013
Cox JohnEVP Pharmaceutical Oper & Tech02/24/201180,847
Cox JohnEVP Pharmaceutical Oper & Tech02/23/201145,397
Clancy Paul JExecutive VP and CFO02/23/201174,704
Gagnon Robert E.Chief Acct Officer VP & Contr02/23/201121,363
Gagnon Robert E.Chief Acct Officer VP & Contr02/24/201152,331
Gagnon Robert E.Chief Acct Officer VP & Contr02/24/201170,606
SCHNEIER CRAIG ERICEVP, HR, Public Affairs & Comm02/23/2011106,682
SCHNEIER CRAIG ERICEVP, HR, Public Affairs & Comm02/25/2011479,540
SCHNEIER CRAIG ERICEVP, HR, Public Affairs & Comm02/25/2011663,245
ALEXANDER SUSAN HEVP, General Counsel02/23/201166,693
Gagnon Robert E.Chief Acct Officer VP & Contr02/17/201149,115
SCHNEIER CRAIG ERICEVP, HR, Public Affairs & Comm02/17/2011214,242
Cox JohnEVP Pharmaceutical Oper & Tech02/17/2011123,620
SCHNEIER CRAIG ERICEVP, HR, Public Affairs & Comm02/12/201197,823
Gagnon Robert E.Chief Acct Officer VP & Contr02/12/201122,448
Cox JohnEVP Pharmaceutical Oper & Tech02/12/201159,905
Clancy Paul JExecutive VP and CFO02/12/2011110,989
ALEXANDER SUSAN HEVP, General Counsel02/12/201199,732
Granata FrancescoEVP Global Commercial Operatio02/01/201190,704
SCHNEIER CRAIG ERICEVP, HR, Public Affairs & Comm01/20/2011310,313
SCHNEIER CRAIG ERICEVP, HR, Public Affairs & Comm01/20/2011428,875
Gagnon Robert E.Chief Acct Officer VP & Contr01/04/2011198,415
Gagnon Robert E.Chief Acct Officer VP & Contr01/04/2011339,690
YOUNG WILLIAMDirector12/31/2010888,815
YOUNG WILLIAMDirector12/31/2010888,750
SCHENK LYNNDirector12/30/2010888,750
SCHENK LYNNDirector12/30/20101,001,988
SCHNEIER CRAIG ERICEVP, HR, Public Affairs & Comm12/17/2010959,080
SCHNEIER CRAIG ERICEVP, HR, Public Affairs & Comm12/17/20101,326,490
Gagnon Robert E.Chief Acct Officer VP & Contr12/06/201052,957
SCHNEIER CRAIG ERICEVP, HR, Public Affairs & Comm12/07/20101,242,834
SCHNEIER CRAIG ERICEVP, HR, Public Affairs & Comm12/03/201084,366
SCHNEIER CRAIG ERICEVP, HR, Public Affairs & Comm12/07/20101,887,850
SCHNEIER CRAIG ERICEVP, HR, Public Affairs & Comm12/03/2010128,150
Gagnon Robert E.Chief Acct Officer VP & Contr12/01/201024,252
Cox JohnEVP Pharmaceutical Oper & Tech11/09/201048,597
Cox JohnEVP Pharmaceutical Oper & Tech11/09/201048,597
Cox JohnEVP Pharmaceutical Oper & Tech11/01/201022,518
Cox JohnEVP Pharmaceutical Oper & Tech11/01/201022,518
Cox JohnEVP Pharmaceutical Oper & Tech11/02/201048,228
Cox JohnEVP Pharmaceutical Oper & Tech11/02/201048,228
PANGIA ROBERT WDirector10/28/2010888,750
PANGIA ROBERT WDirector10/28/2010960,000
Cox JohnEVP Pharmaceutical Oper & Tech10/28/2010234,393
Cox JohnEVP Pharmaceutical Oper & Tech10/28/2010234,393
Cox JohnEVP Pharmaceutical Oper & Tech10/28/2010434,700
Cox JohnEVP Pharmaceutical Oper & Tech10/28/2010434,700
MacLean Michael FSVP, Chief Accounting Officer10/01/201053,873
Clancy Paul JExecutive VP and CFO09/04/201062,651
DORSA CAROLINEDirector08/13/20109,985
MacLean Michael FSVP, Chief Accounting Officer08/02/2010542,457
MacLean Michael FSVP, Chief Accounting Officer08/02/2010542,457
Clancy Paul JExecutive VP and CFO08/01/201046,660
ALEXANDER SUSAN HEVP, General Counsel08/01/201046,660
DORSA CAROLINEDirector07/30/20109,986
Load More Insider Transactions
FUNDS WITH A POSITION IN BIOGEN INC
Fund# Shares Owned% of Portfolio% ChangeInvesting Style
BLACKROCK INC.14,246,6580.09%1.95%Other
GEODE CAPITAL MANAGEMENT, LLC3,309,3170.09%2.24%Other
RENAISSANCE TECHNOLOGIES LLC758,6060.3%-30.17%Other
ORBIMED ADVISORS LLC827,6004.28%48.64%Other
RA CAPITAL MANAGEMENT, L.P.532,8922.15%No changeOther
PALO ALTO INVESTORS LP380,4178.87%-0.23%Other
PARNASSUS INVESTMENTS, LLC360,7420.21%No changeGrowth At A Reasonable Price
ADAGE CAPITAL PARTNERS GP, L.L.C.355,8080.19%484.3%Other
BALYASNY ASSET MANAGEMENT L.P.317,3020.15%37.71%Event Driven
AQR CAPITAL MANAGEMENT LLC37,1400.02%-87.89%Other
D. E. SHAW & CO., INC.23,9350.00541%-91.42%Other
CANDRIAM S.C.A.185,2850.33%-20.8%Other
BRIDGEWATER ASSOCIATES, LP143,2860.21%-5.03%Other
FISHER ASSET MANAGEMENT, LLC63,7780.00873%-43.96%Other
CAPITAL WORLD INVESTORS34,2000.00157%NewGrowth At A Reasonable Price
PLATINUM INVESTMENT MANAGEMENT LTD24,0200.25%-0.1%Growth At A Reasonable Price, Value
UBS OCONNOR LLC4,8790.09%-77.82%Value
GOTHAM ASSET MANAGEMENT, LLC3,6840.02%-81.06%Other
GABELLI FUNDS LLC14,7000.03%-0.47%Event Driven, Growth, Activists
UBS OCONNOR LLC10,000 (Call)0.00316%NewValue
D. E. SHAW & CO., INC.7,500 (Put)0.0017%No changeOther
EASTERLY INVESTMENT PARTNERS LLC5,0840.14%-25.91%Other
MOTLEY FOOL ASSET MANAGEMENT LLC3,9690.08%-0.58%Growth At A Reasonable Price
TUDOR INVESTMENT CORP ET AL3,900 (Call)0.00813%NewEvent Driven, Other
FULLER & THALER ASSET MANAGEMENT, INC.2,1980.00288%39.47%Other
MAVERICK CAPITAL LTD1,6000.00831%NewGrowth At A Reasonable Price, Growth
TUDOR INVESTMENT CORP ET AL900 (Put)0.00188%NewEvent Driven, Other
CHANGE IN SHARES OUTSTANDING FOR BIOGEN INC
STOCK BUYBACKS FOR BIOGEN INC
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
12/31/2023
09/30/2023
0.76%
1Q
12/31/2023
06/30/2023
0.27%
2Q
12/31/2023
03/31/2023
0.48%
3Q
12/31/2023
12/31/2022
0.34%
4Q
12/31/2023
09/30/2022
0.76%
5Q
12/31/2023
06/30/2022
-0.21%
6Q
12/31/2023
03/31/2022
-1.15%
7Q
12/31/2023
12/31/2021
-1.08%
8Q
12/31/2023
09/30/2021
-1.82%
9Q
12/31/2023
06/30/2021
-2.80%
10Q
12/31/2023
03/31/2021
-4.20%
11Q
12/31/2023
12/31/2020
-5.32%
12Q
12/31/2023
09/30/2020
-7.19%
13Q
12/31/2023
06/30/2020
-9.32%
14Q
12/31/2023
03/31/2020
-15.71%
15Q
12/31/2023
12/31/2019
-18.08%
16Q
Load More

Period of Report: 12/31/2023

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
09/30/2023
0.76%
1Q
06/30/2023
0.27%
2Q
03/31/2023
0.48%
3Q
12/31/2022
0.34%
4Q
09/30/2022
0.76%
5Q
06/30/2022
-0.21%
6Q
03/31/2022
-1.15%
7Q
12/31/2021
-1.08%
8Q
09/30/2021
-1.82%
9Q
06/30/2021
-2.80%
10Q
03/31/2021
-4.20%
11Q
12/31/2020
-5.32%
12Q
09/30/2020
-7.19%
13Q
06/30/2020
-9.32%
14Q
03/31/2020
-15.71%
15Q
12/31/2019
-18.08%
16Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR BIOGEN INC
LOADING...